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Abstract
The nucleus of mammalian cells has been proven to be highly organised. A
recent study on interphase chromosome positioning has identied low serum
induced rapid chromosome repositioning. Chromosome 10 initially localised
at an intermediate position in normal proliferating human dermal broblasts
(HDF) was found to relocate to the nuclear periphery 15 minutes after the cells
have been incubated in low serum. Whereas chromosome X has remained in
a peripheral position. The relocation of chromosome 10 has been shown to
be dependant on both actin and myosin functions. In this project we have
further investigated the possible role of nuclear myosin I in chromosome 10
repositioning. Using siRNA to block the expression of the nuclear myosin I
(NMI) we were able to identify this nuclear myosin as necessary for the rapid
repositioning of chromosome 10. Furthermore, using image analysis software
we investigated the eect of the NMI knock down on the overall nuclear size
and shape. The analysis has revealed that while the nuclear size of normal
proliferating cells remained unchanged after the low serum incubation both
in cells expressing the NMI and NMI depleted cells, the knock down of the
NMI seems to have aected the nuclear shape when the cells were subjected
to the serum incubation. On the other hand, the analysis of the chromosome
territories area has revealed signicant dierences in the chromosome territories
sizes before and after the low serum incubation, in normal proliferating HDF
cells .
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Chapter 1
Introduction
1.1 Architecture of the nucleus
The eukaryotic cell nucleus, gure 1.1 houses most of the genetic material of
the cell. It accommodates all the materials and structures necessary for genome
replication and DNA repair, timely control of gene expression and processing
of transcripts. To perform these functions eciently, the nucleus is extremely
well organised with several individual nuclear structures providing architecture
to maintain the nuclear integrity and participate in nuclear processes (Foster &
Bridger 2005).
1.1.1 Nuclear envelope
The nuclear envelope (NE) surrounds the nucleus, and consists of two sheets
of membrane with a lumen, with the inner and outer membranes connecting
only at the nuclear pores (Voeltz, et al., 2002). It serves in the transit of ma-
terials between the nucleus and cytoplasm (Stoer, et al., 1999). The nuclear
pore complexes are highly complex structures that selectively regulate the tran-
sit of larger molecules in both directions, they allow the free passage of small
molecules, whereas, above 50 kilodaltons molecular weight, only "nuclear" pro-
teins are allowed in the nucleus (Laskey, 1987).
1
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Figure 1.1: Cartoon showing the nuclear architecture
This cartoon representation of the nucleus shows some of the actin and myosin
identied locations and interactions, inluding; transcription machinery, nuclear
pore complex, nucleolus, emerin and nuclear lamina.
1.1.2 Chromatin and Chromosomes
Dierent patterns of interphase chromosome organization have been identied
in functionally distinct cell types (Manuelidis & Borden 1988). In the nucleus
of mammalian cell, the chromatin exists in the form of chromosome territo-
ries that can be visualized by uorescence in situ hybridization (FISH) using
whole-chromosome DNA probes (Misteli & Spector 1998). In these chromo-
some territories, chromosomal sub-domains have been shown to occupy distinct
non random sub-nuclear localization depending on the cell's cycle (Manuelidis,
1984). Chromosomes occupy distinct territories in the cell nucleus with pre-
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ferred nuclear locations (Cremer, et al., 2006). Using radial distance mea-
surements Cremer's group has suggested that chromosomes have a probalistic
three-dimentional position (Bolzer, et al., 2005) rather than a determinate one
as previously concluded by Bickmore group in their studies on chromosome 18
and 19 positioning (Croft, et al., 1999). Cremer et al, found that small chro-
mosomes were distributed signicantly closer to the center of the nucleus or
prometaphase rosette, while large chromosomes were located closer to the nu-
clear or rosette rim. This arrangement was conrmed in two cell types with at-
ellipsoidal cell nuclei (human broblast and amniotic uid cell nuclei). in the
same study Cremer's group, had reported that gene-poor chromatin domains,
formed a layer beneath the nuclear envelope, while gene-enriched domain are
found in the nuclear interior (Bolzer, et al., 2005).
Measurements of the chromosome HSA18 and 19 territories, showed areas
of HSA18 signals were signicantly smaller than those of chromosome 19 de-
spite that their DNA content being 85 Mb and 67 Mb respectively (Croft, et
al., 1999). To address whether the spatial organization of the genome aects
the gene expression, or whether it is just a reection of it, Bikemore's group in
2007, have actively induced the rearrangement of some chromosmes to the nu-
clear periphery by tethering them to the inner nuclear membrane (INM). The
repositioning of chromosome 4 and 11 to the nuclear periphery resulted in a
down- regulation of some of their active genes, but not all of them, with the
expression of genes closer to the tethering point being the most aected (Finlan,
et al., 2008).
Cremer, et al., (2000) have proposed a modular and dynamic model for chro-
mosome territory based on three nuclear compartments; an "open" higher-order
chromatin compartment, a "closed" chromatin compartment, and an interchro-
matin domain (ICD) compartment (Zirbel, et al., 1993). While the "open"
chromatin compartments contain active genes , "closed" chromatin compart-
ments comprise inactive genes, and the (ICD) includes macromolecular com-
plexes necessary for DNA replication, transcription, splicing, and repair. Only
1.1. Architecture of the nucleus 4
Genes in "open" compartments would have access to transcription and splicing
complexes located in the ICD compartment (Cremer, et al., 2000)
1.1.3 Nuclear bodies
PML nuclear bodies (PML-NBs)
The promyelocytic leukaemia protein (PML) nuclear bodies (NBs), previously
known as nuclear domains-10, Kremer bodies and PML oncogenic domains are
punctate nuclear structures that are interspersed between chromatin (Melnick
& Licht 1999). PML-NBs are present in most mammalian cell nuclei as discrete
nuclear foci, 0.2-1.0 m wide. Depending on the cell type, cell-cycle phase
and dierentiation stage their number varies between 1 - 30 bodies per nucleus
(Dellaire & Bazett-Jones 2004). Despite their uniform appearance, PML-NBs
are structurally and functionally heterogeneous and are dynamic structures.
Although the main role of PML-NBs seems to be tumour-suppressive (Salomoni
& Pandol 2002), they have been implicated to have a role in regulating many
cellular functions, from inhibiting cell proliferation, to inducing apoptosis and
cellular senescence. Along with, maintaining genomic stability and antiviral
responses (reviewed by Bernardi & Pandol 2007).
Cajal bodies
Cajal bodies are dynamic nuclear bodies of 0.2-1.0 m in diameter, previously
called coiled bodies thought to play a role in small nuclear ribonucleoprotein
(snRNP) biogenesis and in the tracking of snRNPs and snoRNPs (Spector,
2001). The number of cajal bodies present in nuclei is variable during dierent
stages of the cell cycle (Zimber, et al., 2004). They have been shown to asso-
ciate with histone loci as well as U1, U2 and U3 gene clusters (Matera, 1999).
Adjacent to cajal bodies, are found Gems, (gemini of cajal bodies) (Spector,
2001) they are characterized by the presence of the survival of motor neurons
gene product (SMN) and an associated factor, Gemin2 (Matera, 1999).
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Nuclear speckles
Nuclear speckles consist of regions in which splicing factors are concentrated
(spector, 1993). By immunouorescence microscopy using anti-splicing-factor
antibodies, speckles can be visualised as irregularly shaped nuclear domain.
They are dynamic structures and their shape, size and number is variable even
within the same cell type, their number depends on the levels of gene expression
and metabolic and environmental signals. In interphase mammalian nucleus the
number of speckles, usually varies between 25-50 (Lamond & Spector 2003).
Also known as splicing factor compartments (SFCs), by light microscopy, they
appear as irregularly shaped entities with a diameter of 1-2 m and correspond
to interchromatin granule clusters (IGCs) under electron microscope (Vecerova,
et al., 2004).
Paraspeckles
Paraspeckles are a relatively newly identied subnuclear body between 0.5-1.0
m in size. These foci were named paraspeckles because they were observed in
the interchromatin space near to, the nuclear speckles but distinct from them
(Fox, et al., 2002). They are restricted to mammalian nuclei and their numbers
vary both within cell populations and depending on cell type (Bond & Fox 2009).
Paraspeckles proteins are dened by their co-localisation with a member of the
mammalian DBHS (Drosophila melanogaster behavior human splicing) protein
family in a subnuclear foci. But recent studies have reported that they are
formed around a long nuclear noncoding RNA (ncRNA) and contain a small
number of proteins involved in transcription and/or RNA processing. They
have been suggested to have a role in controlling gene expression by trapping
adenosine to inosine (A to I) hyperedited RNA within the nucleus (reviewed by
Bond and Fox 2009).
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1.1.4 Nuclear matrix
The nuclear matrix was revealed (Rando, et al., 2000); after extracting most
the DNA and the histones, to comprise inner laments organized in a three-
dimensional anastomosed network and bounded by the nuclear lamina con-
nected to the cytoskeletal framework. The laments range in diameter from 3
to 22 nm. The proteins of the nuclear matrix are very dierent from those of
the cytoskeleton and chromatin. Although some researchers view the nuclear
matrix as a functionally dened organelle in the nucleus, many other researchers
prefer to refer to it as a biochemical fraction (Rando, et al., 2000). The matrix
is thought to function in some ways as a nuclear homologue of the cytoplasmic
cytoskeleton, providing an organisational scaold upon which nuclear events
might take place.
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1.2 Nuclear motors
Introduction
Active transport in the cell is mostly driven by molecular motors. There are
three classes of molecular motors: the kinesin families that move toward the
plus-end of microtubules, the dynein families that move toward the minus-
end of microtubules, and the unconventional myosin motors that move along
actin laments (reviewed by Mallik and Gross, 2004). While, the discovery in
the nucleus of actin (reviewed by Bettinger et al., 2004) and more recently of
a nuclear isoform of the myosin I (Nowak, et al., 1997) has opened a whole
new horizon of our understanding of some of the fundamental nuclear processes
involving this nuclear motor, more studies are needed to fully understand, many
of the functions allocated to the actin-myosin complex.
1.2.1 Nuclear actin
There are at least six actin genes in mammals encoding for six isoforms (,
 and ). These are alpha-skeletal (ACTA1), alpha-cardiac (ACTC1), alpha-
smooth muscle (ACTA2), gamma-smooth muscle (ACTG2), beta-cytoplasmic
(ACTB) and gamma-cytoplasmic isoactin (ACTG1) (Vandekerckhove & Weber
1987). The  actin isoforms are present in various muscle cells and are involved
in contractile structures, while  actin and  actin isoforms are present in all
cell types (Bettinger, et al., 2004).  actin is a globular protein that is separated
into two lobes by a cleft that forms the ATP-binding site as illustrated in gure
1.2.
ATP-bound actin monomers (globular or G-actin) can assemble into la-
ments (lamentous or F-actin), which results in the hydrolysis of ATP (Bet-
tinger, et al., 2004). Actin laments are composed of two strands that twist
around one another to form a double right-handed helix as shown in gure 1.3.
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Figure 1.2: Cartoon representation of a globular actin molecule
In the cleft region, ATP binding is shown in red and Mg+ in yellow, the dierent
molecule regions are noted 1 to 4.
Figure 1.3: Double helix strand of F actin.
(Available at www.daviddarling.info/images/actin.lament.jpg). Light blue: G actin
molecule. Actin laments are formed by the twist of two strands (blue and purple)
one another around to form a double right-handed helix.
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Actin in the nucleus
Actin was rst revealed in the nucleus in the late sixties (lane, 1969), but
the low amounts of nuclear actin relative to cytoplasm, the inability to detect
nuclear actin using conventional staining methods, and the lack of a specic
function for actin in this compartment led to scepticism (reviewed by Pederson
& Aebi 2002 and Bettinger, et al., 2004). Gonsior, et al., (1999) presented
undisputed evidence of actin presence in the nucleus using a particular anti-
actin monoclonal antibody (2G2) directed against parts of the cleft region of
the actin molecule. Immunouorescence studies revealed a distinctive focal
pattern of nuclear staining in dierentiated myogenic cells, as well as a brillar
structures in nuclei of Xenopus oocytes (Gonsior, et al., 1999). At present,
although the presence of actin in the nucleus is undisputed, the molecular con-
formation and role in nuclear processes of this molecule is yet to be completely
uncovered (reviewed by Pederson & Aebi 2002, Bettinger, et al., 2004 and Var-
tiainen, 2008). McDonald, et al., (2006) reported that the actin pool in the
nucleus contains monomeric, oligomeric and polymeric populations that pre-
sented as both rapidly and slowly moving kinetic populations and that the only
signicant dierence between the cytoplasmic and nuclear actin is the bundling
of cytoplasmic actin that generates the stress bers in the cytoplasm. They
also suggested that around 20% of the total nuclear actin pool has proper-
ties of polymeric actin that turns over rapidly. Moreover, Hu, et al., (2004)
have previously reported that beta actin is associated with and is necessary for
the function of the RNA polymerase III and it has been suggested that the
monomeric actin is the form of actin required for pol III transcription. On
the other hand, dierent studies have suggested that nuclear actin does not
form long F-actin laments, but can undertake a shorter, potentially novel con-
formations that are distinct from those found in conventional actin laments
in the cytoplasm (Pederson & Aebi 2002, 2005 and Jockusch, et al., 2006).
In the nucleoli of resting cells, actin was found to predominantly localised to
brillar centres (FCs). After transcriptional activation of phytohemagglutinin
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(PHA) stimulated human lymphocytes, actin was found to accumulate in the
dense brillar component (DFC) and in the granular component of the nucle-
olus, but FCs remained the main site of actin localisation. Moreover, in the
nucleoplasm of transcriptionally active cells, both actin and NMI colocalised
with nucleoplasmic transcription sites at the decondensed chromatin, after they
were mostly localised in condensed chromatin (Kysela, et al., 2005).
Actin transport into and out of the nucleus
Thanks to its small size, actin can easily enter the nucleus by diusion, however
the low concentration of nuclear actin compared to the cytoplasm suggests
the involvement of an active form in actin transport through the nuclear pore
complex (NPC) (reviewed by Vartiainen, 2008). Wada, et al.,(1998) reported
that actin sequence contains two functional leucine-rich type nuclear export
signal (NES) sequences. The rapid export of injected monomeric actin into the
nucleus was prevented by leptomycin B (LMB), a specic inhibitor of NES-
dependent nuclear export and the disruption of these NES resulted in a nuclear
accumulation of the actin. This was supported by the fact that the export
receptor Exportin 6 (EXP6), was found to mediate nuclear export of prolin-
actin complexes. Prolin was found to highly enhance the primary actin contact
with the exportin 6, and was considered as a cofactor of actin export (Stuven, et
al., 2003). Furthermore, EXP6 was found to recognise and specically remove
actin from the nucleus (Jockusch, et al., 2006). On the other hand there is
evidence that many proteins that binds actin such as colin (Lida, et al., 1992
and Pendleton, et al., 2003) CapG (De Corte, et al., 2004) and MAL (Vartiainen,
et al., 2007) contain a nuclear localization signal (NLS) and may transport actin
in a complex ('piggy-back' it) into the nucleus (Jockusch, et al., 2006, Yahara,
et al., 1996 and reviewed by Vartiainen, 2008).
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Actin binding proteins
In the cell, the majority of actin molecules are bound to individual partners and
consequently locked in a specic conformation, these induced conformational
states eventually lead to distinct forms of monomeric, oligomeric or polymeric
actin but the exact conformation of the actin bound to these proteins is only
known in a few cases, since actin-binding proteins might trigger the formation of
dierent forms of actin. Many of the proteins reacting with conventional actin
forms in the cytoplasm are also found in the nucleus (Jockusch, et al., 2006),
these include F-actin-binding proteins such as gelsolin (Nishimura, et al., 2003),
CapG (De Corte, et al., 2004), myopodin (Weins, et al., 2001) and colin (Lida,
et al,. 1992), as well as the G-actin-binding proteins prolin (Skare, et al., 2003)
and thymosin 4 (Hu, et al., 2004).
A list of actin binding proteins shown to be present in the nucleus, as re-
ported by Pederson and Aebi, (2005) is shown in table 1.1, the original table has
been slightly modied by adding functions to some proteins (Prolin I, CapG)
initially listed as unknown in the original table , the respective references are
also provided.
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Protein Function Reference
Prolin I Monomer binding protein
that promotes nucleotide
exchange
(Skare, et al., 2003),
(Stuven et al., 2003)
Thymosin4 G-actin sequestering pep-
tide in the nucleus
(Hu, et al., 2004)
Myosin I RNA polymerase I tran-
scription
(Fomproix & Percipalle
2004), (Philimonenko,
et al., 2004), (Pestic-
Dragovich, et al., 2000)
Filamin Androgen receptor action Ozanne et al(2000)
Supervillin Androgen receptor action (Ting, et al., 2002)
Gelsolin Androgen receptor action (Nishimura, et al., 2003)
CapG Binds pointed ends of F-
actin
(De Corte, et al., 2004),
(Onoda, et al., 1993)
Emerin Cortical network at the in-
ner nuclear membrane
(Holaska, et al., 2004)
Band 4.1 Nuclear pore-attached la-
ment association
(Kiseleva, et al., 2004)
Tropomodulin Unknown (Kong & Kedes 2004)
NUANCE Linkage to cytoplasmic
actin laments
(Zhen, et al., 2002), (Li-
botte, et al., 2005)
hnRNP U RNA polymerase II tran-
scription
(Kukalev, et al., 2005)
DNA helicase
II/ RNA heli-
case A
RNA polymerase II tran-
scription and RNA process-
ing
(Zhang, et al., 2002)
Zyxin Promotes actin polymeriza-
tion
(Nix and Beckerle 1997),
(Fradeliziet, et al., 2001)
Myopodin Filamentous actin bundling
protein
(Weins, et al., 2001)
Nrf2 Forms a complex with actin
that translocates to the nu-
cleus upon oxidative stress
(Onoda, et al., 1993)
Lamin A nuclear lamina protein (Sasseville, et al., 1998),
(Shumaker, et al., 2003)
Table 1.1: Actin-binding proteins in the nucleus
(adapted from Pederson & Aebi 2005)
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Nuclear complexes that contain actin
Actin has been found to be a component in many nuclear complexes, hence
involved in many nuclear processes, a list of those complexes along with a brief
description of each complex as reported by Bettinger, et al., (2004) is provided
in table 1.2.
This plethora of actin binding proteins in the nucleus suggests that actin
is multifunctional in this compartment. Whether actin takes one or many un-
conventional forms in the nucleus, and which form for which job is yet to be
identied. One actin binding protein recently identied in the nucleus is the
nuclear myosin I (Pestic-Dragovich, et al., 2000) this molecule has been the
focus of our study as there are strong indications that it may be implicated in
chromosome repositioning.
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The complex Function
BAF complex Actin is required for the optimal ATPase activity
of the BAF (BRG-associated factor) complex, a
mammalian chromatin-remodelling complex that
is related to the yeast SWI/SNF complex
BAP complex Actin co-puries with Brm, a SWI2/SNF2-related
helicase that functions as the catalytic subunit
of the BAP(Brm-associated protein) complex,
a Drosophila melanogaster chromatin-remodelling
complex
Ino80 complex Actin co-puries with INO80, which is the ATPase
subunit of the Ino80 complex, a Saccharomyces
cerevisiae SWI/SNF-like complex that is involved
in transcription and DNA processing
NuA4 complex Actin co-puries with the NuA4 (nucleosomal
acetyltransferase of H4) complex, that modies hi-
stones H4 a structural component of the nucleo-
some and H2A
Nuclear
DNA helicase-
II(NDHII)
(NDHII) binds actin and hnRNP C24.it unwinds
double-stranded DNA and has been seen to stimu-
late translation and have a role in RNA transport
p400 complex Actin co-puries with p400 complex the mam-
malian SWI/SNF-like ,which binds to the aden-
ovirus E1A oncoprotein, and is involved in the
oncogenic transformation of cells by E1A.The p400
is also found in the TIP60 complex
PBAF complex Actin co-puries with BAF180, a protein that is
found in the PBAF(polybromo BRG1-associated
factors) complex which localizes to the kineto-
chores of mitotic chromosomes complex
Pre-mRNP parti-
cles
Actin binds to the heterogeneous nuclear ribonu-
cleoproteins (hnRNPs); hrp36, DBP40 and hrp65.
pre-mRNA molecules associate with the hnRNP to
form ribonucleoprotein complexes that are known
as pre-mRNP particles
TIP60 complex Actin co-puries with Tat interactive protein
TIP60, a histone acetylase of the mammalian
TIP60 complex, which also has ATPase and DNA-
helicase activity
Table 1.2: Nuclear complexes that contain actin
(as described by Bettinger, et al.,2004)
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1.2.2 Nuclear Myosin I
Introduction
According to an analysis of the draft human genome conducted by Cheney
et al., (2001) the human genome includes around 40 myosin genes, This fam-
ily can be divided in two major families; the conventional myosins or Class
II myosins consisting of 15 genes, mainly involved in muscle contraction and
the unconventional myosins family which constitute around two thirds of the
human myosins genes. Myosin superfamily members are characterised by the
presence in their heavy chain of a conserved catalytic domain ( 80 KDa), that
is followed in most myosins, by one or more IQ (calmodulin-binding) motifs
in addition to a C-terminal tail and /or an N-terminal extension, these are
thought to confer class-specic properties such as kinase activity and mem-
brane binding. In spite of the high relative conservation of motor domains
among the myosin classes, signicant dierences are found in biochemical and
enzymatic properties of these motor domains. These dierences confer to each
class of myosin specic characteristics, hence dierent roles (Cheney et al 2001).
Nuclear myosin I is a member of the myosin I family (Pestic-Dragovich, et
al., 2000), members of this family was were rst described by Pollard and Korn
in 1973 in Acanthamoeba. Single headed, the myosin I was rst thought to be a
proteolytic form of the myosin II, gure 1.4. It was in 1987 that Hammer et al,
nally provided undoubted evidence of its individuality by cloning the myosin I
gene.
In mammalian cells, myosin I was found to be abundant in the brush border
where it may mediate membrane tracking, it has an important role in function
of the hair cell, it has also been implicated in traction-mediated cytossion and
contractile vacuole function in Dictyostelium (Homan et al 2006). Another
role of myosin I as a molecular tension sensor has also recently been reported
(Laakso, et al., 2008).
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Figure 1.4: Cartoon of myosin I.
Schematic representation of the myosin I molecule with the dierent regions of the
molecule; Red: the head region or the motor domain, orange: the neck region
comprising the regulatory domain and green: the tail region or the binding domain.
The relatively recent discovery of new members of the unconventional myosin
I subfamily in human cells together with the fact that homologous in other
species have been given dierent but yet close similar names, has given rise to
much confusion in the literature. For this reason a group of leading scientists in
the eld had come together in 2001 to recommend the adoption of a common
nomenclature based on the Human Genome Organization (HUGO) names sys-
tem. Names and corresponding coding genes for the myosin I family members
are shown in table 1.3.
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Human
gene
Human
synonyms
Mouse
gene
Mouse
synonyms
Rat
synonyms
MYO1A
Brush border
myosin I
(AF009961)
"myosin-IA"
(L29137)
Myo1a
MYO1B "myosin IB"
(L29138)
Myo1b myosin I
(P46735),
MIHC L
(X69987)
myr 1
(X68199),MI-
130K
MYO1C
Nuclear myosin I Myo1c myosin-I
(X98507)
myr 2
(X74800);
MI-110K
MYO1D Myo1d myosin-I
(C45438)
myr 4
(X71997)
MYO1E
"myosin IC"
(U14391)
Myo1e myr 3
(X74815)
MYO1F "myosin ID"
(U57053),"myosin-
IE" (X98411)
Myo1f myosin-If
(X97650)
MYO1G
Myo1g
MYO1H Myo1h
Table 1.3: Reconciliation of myosin I names in the literature
(adapted from Berg, et al., 2001)
The Nuclear Myosin I (NMI)
Since the mid-seventies, many studies have suggested the nuclear presence of
a myosin or a myosin-like protein but no conclusive evidence was provided
(Hofmann, et al., 2006 and references therein). It was in 1997, that pres-
ence of a myosin I isoform in the nucleus was rst demonstrated (Nowak, et
al., 1997), then conrmed to be a myosin I b (Pestic-Dragovich et al., 2000).
Nuclear myosin I is a 120 kD monomeric single headed actin based motor
molecule pertaining to the Myosin-I subclass of the Myosin superfamily. Mem-
bers of this myosin class have a single globular motor domain, followed by a
neck region and a relatively short (30-40 kD) tail domain. This latter domain is
highly basic and binds to acidic phospholipids (Gillespie, et al., 2002). Like all
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biochemically characterized unconventional myosins, Myosin I binds calmodulin
in its light chain neck region (Barylko, et al., 1992). The human nuclear myosin
I (NMI) is encoded by the MYO1C gene, it is slightly shorter than its cyto-
plasmic homologue and contains a unique 16-amino acid N-terminal extension
that is necessary for its nuclear localisation. Although this extension was not
found to include a known nuclear localisation signal (NLS) sequence, removing
it resulted in retention of the NMI in the cytoplasm (Pestic-Dragovich, et al.,
2000). The localization of myosin I to the nucleus has been shown to predate
the origin of the vertebrates, as NMI has been present in the last common an-
cestor of vertebrates and tunicates. Thus, a functional role for NMI appears
to have been present at an early stage of animal evolution prior to the rise
of both the myosin IC isoform and the vertebrates (Hofmann, et al., 2009).
NMI has been found to be expressed in all mouse tissues with the exception of
terminal stages of spermiogenesis cell nuclei and has a minimum life span of 16
hours (Kahle at al., 2006). Despite its ubiquitous expression, the NMI level is
considerably variable in dierent tissues, suggesting a tissue specic roles for
this myosin. With the highest level in lung cell nuclei, higher levels of the NMI
have also been registered in cell nuclei of kidney, skin, small intestines, liver,
spleen, testis, and heart tissues. Whereas, lower levels have been detected in
brain, skeletal muscle and pancreas (Kahle, et al., 2007).
The level and distribution of NMI in the cell nucleus has been shown to be
dependent on the transcriptional state of the cell (Kysela, et al., 2005); tran-
scriptional activation in phytohemagglutinin (PHA) stimulated human lym-
phocytes was followed by an increase of NMI level and a redistribution of its
initial nuclear localization. While NMI was located mainly to the dense brillar
component (DFC) in nucleoli of resting cells a post-transcriptional activation
condensation of the NMI in the DFC and in the granular component of the nu-
cleolus was observed. Furthermore, in transcriptionally active cells, both actin
and NMI colocalized with nucleoplasmic transcription sites at the decondensed
chromatin, after they were mostly localized in condensed chromatin (Kysela,
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et al., 2005). Expression of NMI has also been found to be aected by serum
variations, with a lower expression level in serum starved cells that increases
after serum stimulation (Kahle, et al., 2007).
1.2.3 Other myosins in the nucleus
The discovery of the nuclear myosin I (Nowak et al 1997) has given rise to the
possibility of the presence of other members of the myosin superfamily in the
nucleus, eectively many studies have reported the presence of several other
myosins in the nucleus, gure1.5.
Myosin V
The phospho-ser1650 myosin Va , a myosin V paralog has been found to lo-
calise at the nucleus( Pranchevicius, et al., 2008); immunouorescence studies
had shown the exclusive colocalization of the phospho-ser1650 myosin Va with
a splicing factor at the nuclear speckles(SC35). Inhibition of transcription in
HeLa cells by actinomycin D has resulted in a dissociation of a fraction of phos-
phoser1650 MVa from SC35 and a redistribution of the phospho-ser1650 MVa
to nucleoli, suggesting a novel role for myosin Va in nuclear compartmentaliza-
tion(Pranchevicius, et al., 2008).
Myosin VI
The myosin VI is the only identied myosin that moves toward the minus end
of actin laments (wells, et al., 1999). Analysis of myosin VI sequence revealed
the presence of ve putative monopartite nuclear localization signals (MNLS)
and one putative bipartite nuclear localization signal (BNLS), mainly localized
in the tail region. Moreover, an immunouorescence study demonstrated the
nuclear localization of the myosin VI (Vreugde, et al., 2006). MyosinVI is a
processive moving myosin, it is present both as monomers and as dimers, the
processive walking of myosin VI on actin laments has been shown to require
dimerization of the molecule, whereas the protein can also function as a nonpro-
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Figure 1.5: Identied nuclear myosins
(unrooted phylogenetic tree of the myosin superfamily in humans) solid lines
indicate myosins known from cDNA sequences and dashed lines indicate
putative myosins predicted from genomic sequence, myosins identied to be
present in the nucleus are highlighted in colored boxes.
(adapted from Berg at al 2001)
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cessive monomer (Ye, et al., 2009). Myosin VI has been reported to be highly
expressed in the nucleus of mammalian cells and modulates RNAPII-dependent
transcription; it has been found to be present in the RNAPII complex and to
specically associates with RNAPII at active genes as well as colocalise with
nascent transcripts (Vreugd, et al., 2006).
Myosin XVIB
Myosin XVIB, is a founding member of the of the class XVI myosins which are
characterized by the presence six ankyrin repeats at the N-terminal that may
function as sites for protein-protein interaction (Berg, et al., 2001). The nuclear
transition of the myosin XVIB, is found to be dependent on the monopartite
nuclear localization signals located in the N-terminal portion of the Myo16b-
tail. Several leucine-rich nuclear export signals (NES) have been also identied
suggesting a controlled nuclear localization of the myosin16 b (Cameron, et al.,
2007). Myosin 16XVIB has been suggested to slow progression through S-phase
and its overexpression suppresses cell proliferation (Cameron, et al., 2007).
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1.2.4 Functions of the Actin- Nuclear Myosin I complex
The actin-NMI complex has been implicated in many nuclear processes from
transport to transcription, in some cases they have been shown to work in
concert, whereas in other occasions they have been shown to have distinct roles;
Chromatin remodeling
The WSTF (Williams Syndrome Transcription Factor)-SNF2h chromatin re-
modeling complex has been reported to interact with the NMI during active
transcription (Cavelln, et al., 2006) Purication of cellular NM1 showed that
a fraction of NM1 was associated with a 2-3 MDa complex, termed B-WICH,
containing WSTF, SNF2h which bound both Pol I and rDNA . Interaction of
NM1 with WSTF was suggested to recruit the WICH and WINAC complex to
active genes to modify chromatin and activate transcription (Percipalle, et al.,
2006).
Transcription
Both actin and NMI cooperate in Pol I transcription activation (Ye, et al.,
2008); antibodies to actin inhibit transcription in cell-free transcription assay
and both actin and NMI are required to rescue transcription in nuclear extract
treated with anti-actin antibody. While, the complex formed by(Pol I, TIF-IA,
actin, and NM1) remained preserved in the presence of ADP, the presence of
ATP, prevented the association of actin with the transcription machinery and
the association of NMI with Pol I was reduced indicateing that ATP binding
and hydrolysis lead to detachment of actin from the Pol I/TIF-IA complex
and dissociation of actin-NMI complex. Whilest, the actin-dependent motor
activity of NMI was identied to be required for transcription elongation and
not for the recruitment of Pol I to rDNA, the tail domain seems to have a
role in earlier steps of transcription (Ye, et al., 2008). Actin was shown to co-
localise with RNA polymerase II and to be recruited to the promoter region of
the interferon-gamma-inducible MHC2TA gene as well as the interferon-alpha-
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inducible G1P3 gene. It was also established to be part of the pre-initiation
complexes of which the formation was prevented by the actin depletion, sug-
gesting that it plays a crucial role in the initiation of transcription by RNA
polymerase II (Hofmann et al 2004). Similarly, NMI has been found to co-
localise and co-immunoprecipitate with RNA polymerase II. NMI Antibodies
to its NH2-terminal extension inhibit transcription by RNA polymerase II in
HeLa nuclear extracts (Pestic-Dragovich, et al., 2000). Similar ndings were re-
ported by Hofmann, et al., (2006) they showed that antibodies to NMI inhibit
transcription both in vitro and in vivo, and this inhibition was found to be in a
concentration dependent manner. Antibodies to NMI inhibited the production
of the rst 15 nucleotides RNA indicating that NMI is involved at the initiation
or pre-initiation state of transcription by RNA polymerase II (Hofmann, et al.,
2006). Furthermore, transcriptional activation in human lymphocytes has been
found to induce a dramatic increase of cellular levels of NMI (the western blot
showed about 15 fold after 24 h and 28 fold after 48 h increase in NMI protein
levels), while the levels of actin remained unchanged (Kysel, et al., 2005). It ap-
pears that NMI is required for transcription initiation and for a post-initiation
steps; as NMI has been found to be part of a multiprotein complex containing
the chromatin remodeling complex WICH (Percipalle, et al., 2006). On the
other hand, beta actin also has a role in RNA polymerase III transcription (Hu,
et al., 2004); beta actin has been shown to associate with highly puried pol
III and is essential for basal transcription. In addition, actin was localized at
the promoter region of an active U6 gene. The dissociation of actin and the
polymerase III resulted in an inactive transcription (Hu, et al., 2004). Nuclear
myosin I was also found to be associated with the RNA polymerase III genes 5 S
rRNA genes and 7SL and was found in complex including WSTF-SNF2h-NMI
that is believed to form a platform in transcription while providing chromatin
remodeling (Cavelln, et al., 2006)
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Nuclear transport
A recent role of the nuclear myosin I and actin has been identied by Parcipalle's
group; using Immunoelectron microscopy, they showed NM1 localization at the
NPC basket of Xenopus oocyte membrane, decorates pore-linked laments rich
in actin. They also found that NMI coprecipitate with CRM1, and Nup153 as
well as same 18S and 28S rRNAs, suggesting a role of the NMI in preribosomal
subunits for maturation and their transport to the NPC (Obrdlik, et al., 2009).
Maintaining the nuclear shape and organisation
The co-localisation of nuclear actin spots and p80 coilin-positive cajal bodies
staining, that resisted nuclear extraction to reveal the nuclear matrix, and the
redistribution of actin to the nuclear periphery identied as a result of Aden-
ovirus 5 infection has led to the conclusion that actin may play an important
role in the organization or function of the cajal body (Gedge, et al., 2005). An-
other role of the nuclear myosin I-containing complexes in sensing and regulating
the mechanical tension at the nuclear envelope has been suggested by Holaska
and Wilson, (2007). They found that emerin scaolds a variety of multipro-
tein complexes at the nuclear envelope that have distinct functions, including
nuclear myosin I-containing complexes, they proposed a model where emerin-
and-lamin A-anchored NMI might pull actin laments towards, or along, the
nuclear envelope. Together with emerin-promoted actin polymerization at the
inner membrane, emerin-bound NMI has the potential to both sense and reg-
ulate the mechanical stiness of the peripheral nuclear lamina network, hence
contribute to maintaining the nuclear shape and architecture (Holaska &Wilson
2007).
Chromatin reorganisation and chromosome movement
A fundamental role for the actin-myosin complex in chromatin movement was
identied by Chang, et al., (2006). They have demonstrated the migration of
a chromosome site from the nuclear periphery to the interior in cells during
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interphase, 1-2 hours after transcriptional activation of this site has been tar-
geted. This chromosomal repositioning has been identied to exist throughout
a large fraction of the cell cycle ( G1 /early S) and depends on NMI and actin
polymerization .
Using 4D imaging analysis, Dundr and colleagues, (2007) revealed rapid and
directed long-range chromosomal movements of U2 genes during interphase.
followed by a stable association between cajal bodies (CBs) and U2 genes.
The interaction of CBs and U2 genes was inhibited by the overexpression of
a nonpolymerisable actin mutant, which also inhibited the repositioning within
the chromosome 7 territory of the U2 locus (Dundr, et al., 2007)
A role of actin and NMI in nuclear reorganisation and interchromosomal in-
teraction has been also identied. Chromosome 21 and chromosome 2, initially
localized independently in the nucleus before 17-estradiol (E2) treatment were
found to became intimately localised after The E2 treatment with interchromo-
somal kissing, this chromosomal rearrangement and kissing was abolished by
the inhibition of actin polymerization or the siRNA depletion of the NMI (Hu,
et al., 2008).
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1.3 Aims of the project
While other studies have reported a role of the nuclear myosin I in chromosome
movement, they have been focusing on a gene or a chromosome region. In
this project the role of the nuclear myosin I in the repositioning of a whole
chromosome territory has been investigated using chromosome positioning and
image analysis tools. This project is aiming to:
1. Conrm chromosome 10 repositioning to the nuclear periphery after the
cells were incubated in low serum, using IPlab spectrum software.
2. Design siRNA constructs to target the respective nuclear myosin I encod-
ing gene.
3. Repeat the chromosome positioning study using images of nuclei where the
nuclear myosin I gene has been silenced by siRNA in order to investigate
the eect of the NMI depletion on low serum induced chromosome 10
repositioning.
4. Conduct a comparative study of the nuclear shape and size before and
after the low serum incubation.
5. Repeat the comparison of the nuclear size and shape after the siRNA
knockdown of the NMI gene.
In order to achieve the above a number of laboratory techniques and image
analysis tools have been used, as detailed in the following chapter.
Chapter 2
Methods and Materials
In this chapter all methods and tools used during this project will be described;
They can be divided in two categories. The rst set is laboratory based, and
the second is computer based. The laboratory based methods section will de-
scribe techniques used to prepare the cells for the study. Tissue culture permits
the generation of enough cells to carry out the experiments. The low serum
assay was used to induce the chromosome repositioning. Fluorescence in situ
hybridisation (FISH), enabled us to probe the chromosomes in order to study
their position in the nucleus before and after the low serum incubation of the
cells, pre and post siRNA knock-down of the nuclear myosin 1 gene. FISH
images, captured in each experiment are subsequently used in the second part
of this Chapter. The computer based methods section will illustrate all the
tools utilised to identify all known myosins in the nucleus, design siRNA con-
structs for the gene knockdown and carry out further analysis on the images
generated from the rst part of the project. Among which, the IP-Lab pro-
gram has provided us with raw data relating to a chromosome's position in the
nucleus; combined with the Microsoft Excel, these data was put into charts
for easy interpretation. Other image analysis tools, including Paint Shop Pro
XI and Scion Image were used to investigate eventual eects of the low serum
assay and the NMI gene silencing on the nuclear size and shape and the studied
chromosomes territories.
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2.1 Laboratory based methods
2.1.1 Tissue culture
Human dermal broblasts (HDFs) 2DD (Bridger, et al., 1993) have been cul-
tured in Dulbeco's Modied Eagles Medium (DMEM) with the following ad-
ditives: 10% new born calf serum (NCS), 1% penicillin, 1 % streptomycin,
L-glutamine. The cells were cultured in 75 mm asks and incubated in 5%
CO2 incubator at 37
C temperature. They were harvested and passaged twice
weekly. To harvest cells, the media and the necessary reagents are pre-heated
to 37C in a water bath before use. In the sterile hood, rst the old media was
removed and the asks were washed with versene (0.197g of EDTA in 1 litre
of 1 X PBS). To facilitate the detachment of the cells from the bottom of the
asks, the cells were incubated in 5 ml diluted solution of trypsin: versene (1:10,
v:v) for up to ve minutes. Meanwhile the cells detachment was checked closely
using a microscope. As soon as all the cells were detached from the ask's
bottom, the trypsin solution was neutralized by adding an equal amount of the
D-MEM medium to the asks. The resulting suspension was then transferred to
centrifuge tubes and centrifuged at 1000 (rpm) for 5 minutes. The supernatant
was removed and the pellet of cells was re-suspended in a known volume of fresh
medium (5 to 10 ml). To determine the number of cells in the suspension, the
haemocytometer was used to count the cells in a drop of the suspension then
the total number of the cells in this was calculated using the following equation:
Number of cells counted on the haemocytometer (CC), divided by number of
haemocytometer's large squares where the cells have been counted (SH), the
result is multiplied by the total volume of the suspension (V) then by 104 , the
nal result equals the total number of the cells in the suspension (TC).
(CC  SH) V  104 = TC
The total volume of the cells suspension was then distributed in new asks at
a density of 5105 cells per ask. The volume in each ask was toped to 20 ml
using fresh media and the cells were incubated at 37C in the incubator.
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2.1.2 Low serum assay
Normal proliferating 2DD were incubated in a low serum medium (0.5% NCS
DMEM) for 15 min to induce the chromosome movement as follows: In the
sterile hood the old media was rst removed and the cultures were washed
twice with serum free fresh media. 20 ml of low serum (0.5% NCS) medium
was added to each ask and the cells were replaced in the incubator for 15
minute then immediately harvested as described above (all the media and the
reagents used are preheated to 37C). After centrifugation the supernatant was
removed and the cells were xed in a 3:1 methanol: acetic acid solution as
described below in the FISH section.
2.1.3 Immuno-uorescence in situ hybridisation
(Immuno-FISH)
Fixation
Fixation was performed using the methanol: acetic acid solution. Firstly, the
cells were harvested using trypsin as described in the previous section, then
after centrifugation most of the supernatant was removed and the cells were
re-suspended in the remaining media. A hypotonic solution (0.075 M KCl) was
added to the cells at room temperature for 15 min. Then, the samples were
centrifuged for ve at 800 (rpm) for 5 minutes, most of the supernatant was
removed and the cells re-suspended in the residual solution. A xative mixture
of methanol:acetic acid (75%:25% respectively) was freshly prepared and put
on ice, then was added drop wise to the sample with constant taping of the
tube to prevent the cells from clumping. The sample was stored at 4C for at
least 1 hour or overnight. The sample was then centrifuged at 800 (rpm) for ve
minutes, the supernatant was removed and the xing procedure was repeated
four to ve times. A drop of the sample was observed under the microscope to
check that most the cytoplasm has been eliminated.
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Slide preparation and denaturation
The xed cells were centrifuged at 1000 (rpm) for 5 minutes, the supernatant
discarded and the pellet of cells re-suspended in a small volume of fresh ice cold
methanol:acetic acid (3:1) solution to obtain a milky suspension. The cells were
dropped from a height onto humid or damp slides. To age the slides they were
rst air dried then baked at 70C for 1 hour or left at room temperature for 2
days. The slides were dehydrated trough in 70%, 90%, 100% ethanol for ve
minutes in each solution at room temperature, then air dried on a hot plate.
Pre-warmed slides (70C for 5 minutes in oven) were incubated in a denaturing
solution (70% formamide : 2X Sodium Saline Citrate (Na3C6H5O7)(V:V),pH
7.0) for 2 minutes, then were immediately plunged in ice cold 70% ethanol for
5 minutes. Next they were run through another ethanol raw (90%, 100% ve
minute in each) at room temperature. After being air dried on a hot plate, the
slides were ready for hybridisation.
Probe preparation and hybridization
In house biotin labelled probes were used (kindly provided by Dr Bridger and
Mehta). First the probe DNA was precipitated into a mixture of Cot DNA and
Herring or Salmon sperm; for each slide:
 8 l of the probe template (10 or X), 7 l of Cot DNA, 3 l of Herring
sperm DNA were mixed.
 Then, 1/10th of the volume (1.8 l) of 3 M sodium acetate (pH 5.0) and
2 volumes (40 l) of ice cold 100% ethanol were added to the mixture.
The mixture was incubated at -80C for at least 30 minutes. Next, it was
centrifuged at 300-400 (rpm) for 30 minutes at 4C. The excess liquid was
discarded and the residual white DNA pellet is then washed by adding 200l
of ice cold 70% ethanol, and then centrifuged again for another 15 min at
4C. The supernatant was removed and the pellet was dried at about 40C
(37 to 50C) on the hot block. When the pallet turned transparent, 12l of
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the hybridization mix (see blow) was added and the pellet was left to dissolve
for at least 2 hours (with gentle tapping every 15 min) or overnight at room
temperature. Next, probes are ready for denaturation by baking them at 70C
for 10 minutes and re-annealing by incubating them at 37C for at least 30 min.
The hybridization mix:
 10% dextran sulphate (V = 2.4 l),
 10% 20 X Sodium Saline Citrate (SSC) (V =1.2 l),
 50% formamide (V = 6 l),
 1% Tween 20 (V = 0.12 l),
 29% double distilled water (V = 2.28 l).
For hybridization, 12l of the probe mixture was applied to each prepared slide,
then covered with a coverslip and sealed with rubber cement. Finally, the slides
were left to hybridise at 37C in a moist chamber for at least 18 hours.
2 D FISH washing and signal detection
After hybridization, coverslips were removed, the slides were washed in buers
A and B as follows; rst, slides were washed in the preheated to 45C Buer A
(50% formamide: 2X SSC (v:v), pH 7) three times for ve minutes and changing
the buer each time. Then the same process is repeated with the buer B (0.1X
SSC, pH 7, preheated to 60C). Next slides were allowed to cool down in a
solution of 4X SCC at room temperature. To detect the uorescent signal, the
slides were rst incubated with 50 to 100 l of a blocking solution (4% bovine
serum albumin) at room temperature for 10 min. Then a similar amount of
(1:200) diluted Streptavidin-Cyanine 3 (Cy3) solution was added to each slide
and incubated in dark for 30 minute at 37C, or 1 hour at room temperature.
Next the slides were washed in a solution of 4X SSC with 0.05% Tween 20, at
42C three times for ve minutes, changing the buer each time. Finally the
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slides were mounted in Vectashield medium + 4, 6-diamidino-2-phenylindole
(DAPI) and were ready for observation by the uorescence microscope.
pKi-67 Staining
To distinguish proliferating cells from non proliferating ones, the 2-D FISH was
combined with anti pKi-67 staining as follows.
2-D FISH slides were placed in a solution of 1X PBS to allow the coverslips
to detach from the slides, then they are incubated with 40 to 100l of the pri-
mary antibody (1:1500 rabbit anti Ki-67, diluted in 1% NCS), for one hour at
room temperature. Slides were washed in 1X PBS for ve minutes three times
to eliminate non bound antibody, then they were incubated with the similar
amount of the secondary secondary antibody conjugated to uorescein isothio-
cynate (FITC) (1:30 diluted in 1% NCS, swine anti-rabbit polyclonal) for one
hour at room temperature. Excess antibody was eliminated by washing the
slides in 1X PBS for ve minutes three times. Finally, slides were mounted in
counter-stain DAPI in vectashield mounting medium (Vector Laboratories).
2.1.4 Image acquisition
The Olympus BX41 uorescence microscope has been used to inspect the slides;
the microscope is equipped with a Viewpoint digital camera (digital scientic).
The cells were examined using a 100X plan oil immersion lens, 50-80 images
of pKi-67 positive, randomly selected nuclei have been captured. The Smart
Capture 3 software was used to visualise a merged colour picture of the three
dierent staining (blue: DAPI, green: Cy3 and red: pKi-67). For each slide a
new lm strip was opened and images saved were in PICT format.
2.1.5 Small interfering RNA (siRNA)
Although, both nuclear myosin I and unconventional myosin VI have been ini-
tially chosen as possible targets for the siRNA knock down, the literature review
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has shown that NMI was more likely to be involved in the chromosome repo-
sitioning as previous studies have identied a role of the NMI in chromatin
movement(see Chapter 1, section 1.3.4), the siRNA experiment was only car-
ried out for the nuclear myosin I. Despite our eorts to design a specic siRNA
construct against the nuclear isoform of the MYO1C gene, it was technically
impossible to generate functionally ecient siRNA constructs against the NMI
5' UTR region of this gene which is the only specic region for the nuclear
myosin I isoform (details provided in section 2.3.3 of this chapter). For this
reason, it was more sensible to opt for ready made and tested constructs. ON-
TARGETplus SMARTpool siRNA (Thermo Fisher Scientic, Lafayette. CO;
Dharmacon Catalog -E-015121-00) has been used to target the nuclear myosin
I. The pool included four specicity-enhanced duplexes that targets dierent
regions of the MYO1C gene, other benets of using a SMARTpool include min-
imum o site eects, since the concentration of each construct is kept very low.
Used sequences are as follows:
 5'GCUCAAAGAAUCCCAUUAU3'
 5'GCUGAAUUCUCGGUGAUAA3'
 5'GCACUCGGCUUGGUACAGA3'
 5'GUACAGCGUGCGGACAAUA3'
For negative control, the cells were transfected using ON-TARGETplus Non-
targeting Pool.
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2.2 Computer Based Methods
2.2.1 Web-based search
The aim of this search was to identify possible other nuclear myosin candi-
dates for the role of chromosome 10 rapid repositioning. First up-to-date data
about all known myosins in the nucleus were collected by searching the protein
databases on the following websites:
 The National Centre for Biotechnology Information: www.ncbi.nlm.nih.gov
 The European Bioinformatics Institute: www.ebi.ac.uk
 The Universal Protein Resource :www.uniprot.org
 Expert Protein Analysis System: www.expasy.org
Dierent key words and searching formulae have been used, in order to es-
tablish a comprehensive and yet specic data about the nuclear myosins. After
identifying all known myosins in the nucleus and respective split variants' se-
quences and encoding genes, the sequences alignment tool ClustralW have been
used to align recognized nuclear myosins sequences with regard to determine
their similarities and align the sequences of splits variant of selected nuclear
myosins in order to identify possible targets for siRNA constructs.
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2.2.2 Sequence alignment tool
The ClustalW2 alignment tool on the European bioinformatics institute's web-
site, gure 2.1, has been chosen to align recognised nuclear myosins sequences
with regard to determine their similarities. This program calculated the best
match for the selected sequences to produce biologically meaningful multiple
sequence alignments of divergent sequences, then lined them up so that the
identities, similarities and dierences can be seen.
Figure 2.1: Alignment tools on the EBI website.
On the EBI website from the tool's window, sequence analysis, then the ClustalW2
tool, which allows the alignment of multiple sequences, was chosen.
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Using ClustalW2, sequences of myosin I and myosin VI have respectively
been lined up together with the other the splits variants encoded by the same
respective gene. This program permits visualisation of peculiar segments of
the myosin I and myosin VI which can be targeted when designing siRNA
constructs.
To align the three transcripts variants of the MYO1C gene together their
respective RNA sequences in a FASTA format were obtained from the NCBI
website; NP-001074248.1 for isoform a, NP-001074419.1 for isoform b (NMI),
NP-203693.3 for isoform c. The three sequences were entered in the designated
space and the program was run using default setting as shown in gure 2.2.
Figure 2.2: ClustalW2 alignment tool settings.
Sequences of the transcript variants were entered in the designated space, the
default setting were selected to run the analysis.
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2.2.3 Design of siRNA constructs
Nuclear myosin I and unconventional myosin VI have been chosen as initial tar-
gets to be investigated for their possible role in the Chromosome 10 low serum
induced repositioning. To generate a list of candidates' sequences for siRNA
targeting MYO1C and MYO6 genes respectively, the siRNA design tool; The
siDESIGN Center on the Dharmacon website (www.dharmacon.com/designcenter)
has been used. This tool allows to choose an identier type (Accession Num-
ber, Gene ID, Nucleotide sequence, GI Number), to select desired region(s) for
siRNA design. Since, the nuclear myosin I is distinguished from other tran-
scripts variants encoded by the MYO1C only by its 5'UTR region, this section
has been initially selected as target region for siRNA design by using the NMI
accession number as identier. Unfortunately, no siRNA candidates could be
built with these given inputs. The next step was to extend the target region
to include the ORF section and specify the transcript target to be the isoform
b of the MYO1C by entering the gene ID (4641). No siRNA candidates could
be built with these given inputs also, the reason why it was decided to use
commercially tried construct and ON-TARGET plus SMARTpool siRNA was
chosen for the MYO1C knock-down.
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2.2.4 Image analysis
Part of the images used in this analysis were kindly provided by Ishita Mehta,
a fellow PhD student, she also gratefully, provided me with the the FISH slides
from which another part of the images were taken. The image analysis was
carried out using a number of software, depending on the aim of the study.
Chromosome positioning
The erosion analysis in IPLab Spectrum software was used to determine the
position of chromosome 10 and X territories in cells at 0 and 15 min before and
after the NMI knock down. For each analysis at 45 to 90 images are used in
PICT format. The images were treated by data erosion program which divides
the nuclear surface into ve concentric zones or shells, zone 1 being the most
peripheral and zone 5 the central. This program measures both the DAPI and
the Cy3 signal in each zone of the nucleus and the nal results are then displayed
in a table. Which was then transferred to Microsoft spreadsheet and used to
for further data analysis; for every image, the chromosome territory signal in
each of the ve shells was normalized to the DAPI signal of the same zone. The
means of the calculated ratios were then plotted into histograms to determine
the position of the chromosome territories; the t-test was used to evaluate the
signicance of the results.
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Nucleus and chromosome territories analysis
This analysis has been carried out in three main steps, dierent software or data
analysis tools has been used in each step depending on the aim of the study.
1. Corel Paint Shop Pro XI: The images obtained from the uorescent mi-
croscope were transformed from a PICT format to a Ti uncompressed
format using a trial version of the "Corel Paint Shop Pro XI". Then each
image was split to the three channel colours RBG (Red Bleu Green) and
saved as Ti to be used for the area analysis, as illustrated in gure 2.3.
Figure 2.3: Corel Paint Shop Pro XI (RGB Split channels)
A:immono-FISH original image before the split (nucleus in blue, chromosome 10
territories in green, nucleolus in red). B: red channel (only the red staining from the
original image is highlighted, corresponding to the FICT staining or the nucleolus).
C: blue channel (only the blue staining is selected corresponding to the DAPI
staining or nucleus). D: Green channel (only the green staining is selected
corresponding to the Cy3 staining or chromosome territories).
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2. Scion image analysis: The Scion image software was used for nuclear and
chromosome territories analysis; it carries out area measurement, as well
as details about contour/ perimeter, minor and major ellipse, mean den-
sity. This tool can only open grayscale images saved in uncompressed
TIFF format. When this software was opened, a bar menu, a tool and
LUT box, an Info and Map window appeared on the screen as illustrated
in gure 2.4.
Figure 2.4: Scion image analysis.
LUT: permits to set and change the gray scale intensity. Tool box: include image
treatment and measurement tools. Info window: displays details about the open
image. Map window: shows the colour distribution
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For nuclear analysis, the blue channel image of each colored nucleus image
was opened using "import" command from the le menu, then the density
slice option was selected which highlights the area of interest in red gure 2.5
according to a gray scale threshold, this could be manipulated using the LUT
window depending on the clarity and the brightness of the picture.
Figure 2.5: Density slice on Scion image.
The LUT box permits to establish a grayscale threshold for the density slice, which
permits to highlight the region of interest.
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Next, on the menu bar the "analyze" window was dropped and the options
command was selected to set the parameter desired to be measured. Figure 2.6.
Figure 2.6: Setting the measurements options.
A: bar menu the analyze drop window is opened and the option command is
selected. B: desired parameters to be measured are checked, including: area,
perimeter, minor ellipse and major ellipse.
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The following step consisted in setting the measurement scale from the anal-
yse command box, gure 2.7, the scale was set to 10.8 pixels per m. this value
has been calculated using a graticule picture.
Figure 2.7: Setting the measurement scale to micrometers.
from the "analyze" drop window, set the scale option was selected and the scale is
set to the desired value.
Microsoft Excel
The raw data obtained from the image analysis software, were transferred to a
Microsoft Excel worksheet for further statistical analysis.
Chapter 3
The role of Nuclear Myosin 1 in
interphase chromosomes
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3.1 Chromosome 10 positioning
Images obtained from FISH slides performed as described in chapter 2, were run
through a simple erosion script using IP-Lab image analysis software, which di-
vided the nucleus into 5 equal concentric shells . The DAPI and Cy3 signals
were measured in each shell. The raw data was then transferred to an Excel
worksheet, the chromosome territory's (Cy3) signal was normalised to the nu-
clear (DAPI) signal in each shell where the mean of the ratio (% of the cy3
signal / % of the DAPI signal) has been calculated for each shell, then plot-
ted in charts. The position of the chromosomes was then dened as periphery,
intermediate or interior. A chromosome territory was identied to locate at
the nuclear periphery, when after normalisation; the mean Cy3 signal was the
highest in shell 1 and 2; intermediate if the shells 2, 3 and 4 had higher probe
signal with shell 3 having the highest signal or all the three shells showed equal
amount of Cy3 signal. Finally, the chromosome position is dened as interior
when the highest probe signal is localised in shells 4 and 5. To identify the role
of nuclear myosin 1 in chromosome 10 repositioning , the low serum inuduced
relocation of chromosome 10 from an intermediate region in the nucleus to the
nuclear periphery was rst conrmed by analysing chromosome 10 positions
before and after the low serum assay. Next the NMI expression has been sup-
pressed, and the low serum assay was repeated using the NMI depleted cells
and chromosome 10 positioning before and after the low serum incubation has
been analysed and compared to chromosome positioning in cells expressing the
NMI. For each experiment 45 to 60 images were analysed .
3.1.1 Chromosome 10 repositioning before and after the
low serum assay
To conrm the low serum induced Chromosome 10 relocation from an interme-
diate region of the nucleus to its periphery 15 minutes after the cells have been
incubated in low serum media, the low serum assay using normal proliferation
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HDF (as described in section 2.2.2 of chapter 2) has been repeated. FISH images
(gure 3.1) of nuclei from control cells (cells at 0 minute; that have not been
incubated in low serum media), and FISH images (gure 3.2) of nuclei after the
low serum assay at 15 minutes), were treated by a simple erosion analysis using
IPLab program as discribed in section 2.3.4 of chapter 2.
Figure 3.1: Sample of chromosome 10 FISH images at 0 minute.
Representative images displaying nuclei prepared for uorescence in situ
hybridization (2D-FISH) before the low serum incubation. With whole-chromosome
10 painting probes (green), nuclear DNA was counterstained with DAPI (blue) and
indirect immunouorescence with anti-pKi-67 antibodies (red staining) permitted
the selection of normal proliferating cells.
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Figure 3.2: Sample of chromosome 10 FISH images at 15 minutes.
Representative images displaying nuclei prepared for uorescence in situ
hybridization (2D-FISH) after the cells have been subjected to the low serum assay.
With whole-chromosome 10 painting probes (green), nuclear DNA was
counterstained with DAPI (blue) and indirect immunouorescence with anti-pKi-67
antibodies (red staining) permitted the selection of normal proliferating cells.
Chromosome 10 position at 0 minute in NMI(+) nuclei
Chromosome 10 in normal proliferating cells before the low serum assay (at 0
minute) has been conrmed to locate at an intermediate region of the nucleus
as the highest cy3 signals were localised in shells 2 and 3, as shown in gure
3.3. Calculated paired t test has conrmed the signicant cy3 signal dierence
between shells 2 and 3 and the other shells.
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Figure 3.3: Chromosome 10 positioning in nuclei of normal proliferat-
ing HDFs at 0 minute.
Displays the distribution of the chromosome 10 signal for 2D FISH before the low
serum incubation, as analyzed with erosion analysis. The percentage of chromosome
signal measured in each shell was divided by the percentage of DAPI signal in that
shell. Bars represent the mean normalised percentage of chromosome 10 signal in
each shell (1-5) with shell 5 being the most intern and 1 the most peripheral.
Chromosome 10 position at 15 minutes in NMI(+) nuclei
After the low serum incubation, Chromosome 10 in normal proliferating HDFs
nuclei is found to relocate to the periphery of the nucleus (gure 3.4), with the
highest chromosome signal (cy3) in shell 1 followed by shell 2, and considerably
lower signals in shells 3 and 4 and nearly null signal in shell 5. the paired t test
for means has conrmed the signicantly dirence between signals in shells 1
and 2 and the rest of the shells. p 6 0.005.
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Figure 3.4: Chromosome 10 positioning in nuclei of normal proliferat-
ing HDFs at 15 minutes.
Displays the distribution of the chromosome 10 signal for 2D FISH after the low
serum incubation, as analyzed with erosion analysis. The percentage of chromosome
signal measured in each shell was divided by the percentage of DAPI signal in that
shell. Bars represent the mean normalised percentage of chromosome 10 signal in
each shell (1-5) with shell 5 being the most intern and 1 the most peripheral.
In order to better visualise the chromosome 10 relocation to the periphery
after the low serum incubation, both charts of chromosome 10 position at 0 and
15 minutes have been aligned in gure 3.5, in blue is chromosome 10 position
before the low serum assay and in pink is chromosome 10 position after the low
serum assay.
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Figure 3.5: Chromosome 10 positioning in nuclei of normal proliferat-
ing HDFs before and after the low serum incubation.
Displays a juxtaposition of the chromosome 10 positioning graphs before and after
the low serum assay in normal proliferating HDFs. Blue: chromosome 10 signals at
0 minute. Pink: chromosome 10 signal at 15 minutes.
3.1.2 Chromosome 10 positioning before and after the
low serum assay in NMI depleted cells [NMI( )]
Low serum assay has been repeated using cells where the expression of the NMI
has been suppressed using ON-TargetPlus NMI siRNA, then FISH images of
Chromosome 10 territories at 0 minute ; before the low serum incubation and at
15 minutes, gure 3.6, then after 15 minutes of low serum incubation, gure3.7
have been subjected to simple erosion using IPlab.
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Figure 3.6: Sample of chromosome 10 FISH images at 0 minute in NMI
depleted cells.
Representative images displaying nuclei prepared for uorescence in situ
hybridization (2D-FISH) before the low serum incubation of NMI depleted cells.
With whole-chromosome 10 painting probes (green), nuclear DNA was
counterstained with DAPI (blue).
Chromosome 10 position at 0 minute in NMI( ) nuclei
The results obtained from the erosion analysis of chromosome 10 FISH images
at 0 minute (before the low serum assay), have been plotted in the chart below,
Chromosome 10 signals are found to be the highest in shell 3 followed by shell
2, indicating an intermediate position of the chromosome 10 territories in nuclei
where the expression of the NMI has been blocked using siRNA, gure 3.8.
Chromosome 10 position at 15 minutes in NMI( ) nuclei
The results obtained from the erosion analysis of chromosome 10 FISH images
at 15 minutes (after the low serum assay), have been plotted in the chart below.
this time also, Chromosome 10 signals are found to be the highest in shell 3 fol-
lowed by shell 2, and 4 indicating an intermediate position of the chromosome 10
territories in NMI( ) nuclei after the low serum incubation, as shown in gure
3.9.
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Figure 3.7: Sample of chromosome 10 FISH images at 15 minute in
NMI depleted cells.
Representative images displaying nuclei prepared for uorescence in situ
hybridization (2D-FISH) after the low serum incubation of NMI depleted cells.
With whole-chromosome 10 painting probes (green), nuclear DNA was
counterstained with DAPI (blue).
Figure 3.8: Chromosome 10 positioning in NMI depleted nuclei before
the low serum assay.
Displays the distribution of the chromosome 10 signal for 2D FISH of NMI( )
nuclei before the low serum incubation of NMI depleted cells analysed with simple
erosion analysis. The percentage of chromosome signal measured in each shell was
divided by the percentage of DAPI signal in that shell. Bars represent the mean
normalised percentage of chromosome 10 signal in each shell (1-5) with shell 5 being
the most intern and 1 the most peripheral.
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Figure 3.9: Chromosome 10 positioning in NMI depleted nuclei after
the low serum assay.
Displays the distribution of the chromosome 10 signal for 2D FISH of NMI( )
nuclei after the low serum incubation of NMI depleted cells analysed with simple
erosion analysis. The percentage of chromosome signal measured in each shell was
divided by the percentage of DAPI signal in that shell. Bars represent the mean
normalised percentage of chromosome 10 signal in each shell (1-5) with shell 5 being
the most intern and 1 the most peripheral.
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3.2 Chromosome X positioning
Chromosome X position in the nucleus was studied in normal proliferating HDF
control, cells before the siRNA silencing of the nuclear myosin I; at 0 minute
(before the low serum assay) then at 15 minute (after incubation in low serum
medium for 15 minutes). The same study was repeated after the siRNA knock-
down of the NMI gene. The results obtained from the IP-lab analysis of pro
and post siRNA images of chromosome X before and after the low serum assay
are displayed in charts as follows:
Chromosome X position at 0 minute in NMI(+) nuclei
Chromosome X in normal proliferating cells before the low serum assay (at 0
minute) has been conrmed to locate at the nuclear periphery as the highest
cy3 signals were registered in shells 1 and 2, as shown in gure 3.10. the paired
t test has conrmed the signicant cy3 signal dierence between shells 1 and 2
and the other shells.
Figure 3.10: Chromosome X positioning in NMI expressing nuclei at 0
minute.
Displays the distribution of the chromosome X signal for 2D FISH before the low
serum incubation, as analysed with erosion analysis. The percentage of chromosome
X signal measured in each shell was divided by the percentage of DAPI signal in
that shell. Bars represent the mean normalised percentage of chromosome signal in
each shell (1-5) with shell 5 being the most intern and 1 the most peripheral.
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Chromosome X position at 15 minutes in NMI(+) nuclei
After the low serum incubation, Chromosome X in normal proliferating HDFs
nuclei is found to locate also to the periphery of the nucleus (gure 3.11),
with the highest chromosome signal (cy3) in shell 1 followed by shell 2, and
considerably lower signals in shells 3 and 4 and nearly null signal in shell 5.
the paired t test for means has conrmed the signicantly dierence between
signals in shells 1 and 2 and the rest of the shells.p 6 0.005
Figure 3.11: Chromosome X positioning in NMI expressing nuclei at
15 minutes.
Displays the distribution of the chromosome X signal for 2D FISH after the low
serum incubation, as analysed with erosion analysis. The percentage of chromosome
X signal measured in each shell was divided by the percentage of DAPI signal in
that shell. Bars represent the mean normalised percentage of chromosome signal in
each shell (1-5) with shell 5 being the most intern and 1 the most peripheral.
3.2.1 Chromosome X positioning before and after the
low serum assay in NMI depleted cells [NMI( )]
Using NMI depleted cells, the low serum assay was repeated and FISH images
of chromosome X before (at 0 minute) and after the low serum assay (at 15
minutes) have been treated through the IPLab simple erosion program. the
chromosome signal (Cy3) in each shell was normalised to the DAPI signal and
the mean result in each shell has been plotted in the charts below.
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Chromosome X position at 0 minute in NMI( ) nuclei
It is evident from the distribution of the chromosome X signals, that this chro-
mosome has a peripheral position in nuclei of NMI depleted HDFs before the
low serum assay. with the highest Cy3 signal registered in shell 1 followed by
shell 2, gure 3.12.
Figure 3.12: Chromosome X positioning in NMI depleted cells at 0
minute.
Displays the distribution of the chromosome X signal for 2D FISH of NMI( )
nuclei before the low serum incubation of NMI depleted cells, analysed with simple
erosion analysis. The percentage of chromosome signal measured in each shell was
divided by the percentage of DAPI signal in that shell. Bars represent the mean
normalised percentage of chromosome X signal in each shell (1-5) with shell 5 being
the most intern and 1 the most peripheral.
Chromosome X position at 15 minutes in NMI( ) nuclei
From the distribution of the Cy3 signals, this chromosome has also a peripheral
position in the nuclei of NMI depleted HDFs after the low serum incubation.
The highest Cy3 signal registered in shell 1 followed by shell 2, gure3.13.
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Figure 3.13: Chromosome X positioning in NMI depleted cells at 15
minutes.
Displays the distribution of the chromosome X signal for 2D FISH of NMI( )
nuclei after the low serum incubation of NMI depleted cells, analysed with simple
erosion analysis. The percentage of chromosome signal measured in each shell was
divided by the percentage of DAPI signal in that shell. Bars represent the mean
normalised percentage of chromosome X signal in each shell (1-5) with shell 5 being
the most intern and 1 the most peripheral.
conclusion
The study of chromosome 10 positions before and after the low serum assay has
permitted the conrmation of the low serum induced chromosome 10 reposi-
tioning from an intermediate position to the periphery of the nucleus. In nuclei
where the expression of the NMI has been suppressed using siRNA, chromosome
10 position before and after the low serum assay did not seem to have changed
from the intermediate position. This indicates that the NMI is necessary for
the low serum induced relocation of the chromosome 10 from the intermediate
position to the peripheral location in interphase HDFs. On the other hand,
chromosome X positioning analysis showed no signicant changes of its posi-
tion. Chromosome X was found to locate at nuclear periphery before and after
the low serum assay in both, NMI depleted and expressing cells.
Chapter 4
Results: Image Analysis
4.1 Analysis of nuclear size
Introduction
The raw data obtained from Scion analysis of the nuclei and the chromosome
territories were transferred to an Excel worksheet where data analysis tools have
been utilized to compare the resulting means of each studied parameter. To test
the statistical signicance of any encountered dierences, the T-test for unpaired
samples assuming unequal variances has been employed; as is convention any
tested dierence is said to be statistically signicant if the calculated t-Stat is
bigger than the given t-Critical for two samples and the value of P is smaller
than 0.05 at 95 % condence intervals. Finally, results have been presented in
charts to aid interpretation .
4.1.1 Investigating the eects of the low serum assay on
the nuclear size
The aim of this study is to investigate any changes in nuclear size that may
have occurred as a result of subjecting the cells to the low serum assay. Since
we have already identied a strikingly rapid chromosome rearrangement as a
result to incubating the cells in low serum for just 15 minutes. It was important
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to these assay, to know whether this chromatin reorganization is accompanied
by any changes in the nuclear size. To achieve this the nuclear sizes of randomly
selected FISH images of normal proliferating HDF cells at 0 minute have been
compared with the nuclear sizes at 15 minutes. The 0 minute refers to samples
of FISH taken from cells before the low serum assay, while the 15 minutes refers
to FISH samples taken from cells after the low serum assay (after the cells have
been incubated in low serum for 15 minute). Only images of cells that had a
positive pKi-67 staining were analysed. Three sets of 40 to 50 images have been
analysed; the rst set was of FISH images performed on cells at passage 12, the
second and third sets of images are derived from the control cells used for the
siRNA experiment, chromosome 10 and chromosome X images respectively.
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First data set
The analysis of the nuclear area before and after the low serum assay in normal
proliferating HDFs at passage 12 shows that the mean nuclear area of cells after
the low serum assay is smaller than that of control cells (before the low serum
assay), as displayed in gure 4.1. The two samples t-test assuming unequal
variances shows a calculated value of t Stat = 3.03 > t critical two tails = 1.99
and P = 0.003 suggesting that the dierence observed between the nuclear size
at 0 and 15 minutes is statistically signicant. Results are listed in table 4.1
Figure 4.1: First comparison of the means nuclear area before and after
the low serum assay.
Blue: nuclear area at 0 minute or before the low serum incubation, Red:nuclear area
at 15 minute after the low serum incubation, all measurements are shown in m2
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t-Test: Two-Sample Assuming Unequal Variances
Nuclear area
at 0 min
Nuclear area
at 15 min
Mean 452.46 350.31
Variance 26898.77 18275.97
Observations 40 40
Hypothesized Mean Dierence 0
df 75
t Stat 3.03951
p(T<=t) one-tail 0.001631
t Critical one-tail 1.665425
p(T<=t) two-tail 0.003262
t Critical two-tail 1.992102
Table 4.1: Signicance test for the nuclear size dierence before and after low
serum assay, data set 1.
Second data set
The analysis of the nuclear area before and after the low serum assay in normal
proliferating HDF was repeated using FISH images from cells at passage 10.
From the results of this analysis it seems that the nuclear area is also smaller
after the low serum treatments of the cells, as shown in gure 4.2.
The t-test this time shows that this dierence is statistically insignicant
with a t Stat<t Critical two tails and p=0.13, results are displayed in table 4.2
t-Test: Two-Sample Assuming Unequal Variances
Nuclear area
at 0 min
Nuclear area
at 15 min
Mean 725.334 659.69
Variance 50240.29954 44060.4481
Observations 50 50
Hypothesized Mean Dierence 0
df 98
t Stat 1.51155
p(T<=t) one-tail 0.066933
t Critical one-tail 1.660551
pT<= t two-tail 0.133866
t Critical two-tail 1.984467
Table 4.2: Signicance test for the nuclear size dierence before and after low
serum assay, data set 2.
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Figure 4.2: Second comparison of the means nuclear area before and
after the low serum assay.
Blue: nuclear area at 0 minute or before the low serum incubation, Red : nuclear
area at 15 minute after the low serum incubation, all measurements are shown in
m2
Third data set
The analysis of the nuclear area before and after the low serum assay in normal
proliferating HDF has been repeated using a third set of FISH images from cells
from the same passage 10 as the previous one. From the results of this analysis
it seems that the mean nuclear area is bigger, after the low serum treatments
of the cells, gure 4.3, but the t-test this time shows that this dierence is
statistically insignicant (t Stat < t Critical two tails and p = 0.14). The
results are displayed below in in the table 4.3.
4.1. Analysis of nuclear size 63
Figure 4.3: Third comparison of the means nuclear area before and
after the low serum assay.
Blue: nuclear area at 0 minute or before the low serum incubation, Red:nuclear area
at 15 minute after the low serum incubation, all measurements are shown in m2.
t-Test: Two-Sample Assuming Unequal Variances
Nuclear area
at 0 min
Nuclear area
at 15 min
Mean 433.19 508.2881
Variance 62326.4 45818.15
Observations 42 42
Hypothesized Mean Dierence 0
df 80
t Stat -1.47996
p(T<=t)one-tail 0.071405
t Critical one-tail 1.664125
p(T<=t) two-tail 0.14281
t Critical two-tail 1.990063
Table 4.3: Signicance test for the nuclear size dierence before and after low
serum assay, data set 3
Conclusion
There is no signicant dierence between the nuclear size of cells subjected to
the low serum assay and control cells. Initially, it seemed that the nuclear size
had become smaller after incubating the cells in low serum for 15 minutes when
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compared to the size of nuclei of control cells (data set 1 and 2). To test the
signicance of this dierence of mean nuclei areas between 0 and 15 minute,
a two samples t-test for unequal variances have been calculated. While, the
calculated t-test for the rst set of data showed that the observed dierence
between the nuclei sizes at 0 and 15 minutes was signicant (t stat = 3.03 >
t critical two tails = 1.99; p = 0.003), the second t-test for data set 2 was
found to be insignicant (t stat = 1.51< t critical two tails = 1.98; p = 0.066
). In data set 3 a dierent trend was observed; it appeared that the nuclear
size increased after the low serum incubation of the cells, this time again the
t-test has indicated that this dierence observed between the nuclei size at 0
and 15 minutes is statistically insignicant (t stat = 1.47 < t critical two tails
= 1.99 ; p= 0.07). It is evident that the dierences observed in the nuclei size
between the cells that have been subjected to the low serum assay and those
that have not been, is statistically insignicant, therefore there are no notable
changes in the nuclei size when the cells have been incubated in low serum for
15 minutes. Thus, subjecting the cells to the low serum assay has not induced
any signicant changes in the nuclear area.
4.1.2 Investigating eects of the siRNA- mediated sup-
pression of NMI on the nuclear size
The aim of this part of the study was to investigate whether the siRNA-mediated
knock down of nuclear myosin I protein resulted in any changes in the overall
nuclear size of the cells. This was achieved by conducting a series of comparisons
of the mean nuclear area of cells where the siRNA transfection have been used to
block the expression of the nuclear myosin I with control cells that have not been
transfected. Next the comparison of the nuclear size before and after the low
serum assay has been repeated in cells where the NMI gene has been silenced.
Then comparing the mean nuclear area of cells incubated in low serum for 15
minutes before and after the nuclear myosin I has been silenced, as follows.
Whenever, a signicant dierence between the NMI(+) nuclei and the NMI( )
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had arisen, the results were compared to the negative control (cells transfected
using the same reagents as used for the NMI transfection but with no NMI
targeting constructs) to conrm that the observed dierence has resulted from
the depletion of the NMI and not from the transfection itself.
1. Comparison of nuclear size before and after the siRNA-mediated knock
down of the NMI (comparing area of NMI(+) or control and area of
NMI( ) nuclei)
2. Repeat the low serum comparison in NMI silenced nuclei (comparing area
ofNMI( )nuclei at 0 minute andNMI( )nuclei at 15 minute of low serum
assay
3. Comparison of the nuclear area after the low serum incubation before and
after blocking the expression of the NMI (control nuclei(NMI(+)) at 15
minutes and (NMI( )) at 15 minutes)
1. Comparison of nuclear size before and after the siRNA-mediated
knock down of the NMI
To investigate whether silencing the NMI gene has aected the overall nuclear
size, a comparison of nuclear size before and after the siRNA-mediated knock
down of the NMI has been done, at rst nuclei expressing NMI(NMI(+)) seemed
to be smaller as compared to nuclei where the NMI expression has been blocked
[NMI( )] as shown in gure 4.4 , but the the calculated two tails unpaired
t test has conrmed this dierence to be statistically insignicant, P(T<=t)
two-tail = 0.31, as displayed in table 4.4
4.1. Analysis of nuclear size 66
Figure 4.4: Comparison of the means nuclear area before and after the
silencing of the NMI.
Blue: nuclear area at before the siRNA knock down of the NMI , Purple: nuclear
area after the siRNA knock down of the NMI, standard error bars have been
plotted, all measurements are shown in m2
t-Test: Two-Sample Assuming Unequal Variances
Mean area of
NMI(+)
Mean area of
NMI( ) nuclei
Mean 452.3768 485.704
Variance 0.002179 0.003219
Observations 50 50
Hypothesized Mean Dierence 0
df 93
t Stat -1.00804
P(T<=t) one-tail 0.157972
t Critical one-tail 1.660715
P(T<=t) two-tail 0.315943
t Critical two-tail 1.984723
Table 4.4: Signicance test for the dierence in nuclear area before and after
the silencing of the NMI.
2. Comparison of the nuclei size before and after the low serum assay
in NMI depleted nuclei(NMI( ))
The low serum assay has been repeated using cells where the expression of
the NMI has been blocked using siRNA (NMI( )). To investigate whether
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subjecting NMI( ) cells to low serum assay has resulted in any signicant
changes in the average nuclear size. Two sets of 40 to 50 randomly selected
FISH images of cells at passage 10 where the NMI gene (MYO1C ) has been
knocked down using siRNA have been analysed, as follows.
First set of data
At rst instance it seemed that in nuclear myosin I depleted cells, the nuclei
were getting slightly smaller after the low serum assay (at 15 minutes) compared
to the initial size before the low serum incubation (at 0 minute), gure 4.5. To
test the signicance of this dierence of nuclear size at 0 and 15 minutes a
two-sample t-test assuming unequal variances has been performed which has
conrmed the non signicance of this dierence with p value = 0.61, as detailed
in table 4.5. This means that there is no statistically signicant dierence in
mean nuclear area before and after the low serum assay in cells after that the
expression of the NMI has been impaired.
Figure 4.5: Comparison of the means nuclear area before and after the
low serum incubation in NMI depleted cells, data set 1.
Blue: nuclear area at 0 minute (before the low serum assay) , pink : nuclear area at
15 minutes (after the low serum assay), standard error bars have been plotted, all
measurements are shown in m2
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t-Test: Two-Sample Assuming Unequal Variances
NMI( ) nu-
clear area at
0 min
NMI( ) nu-
clear area at
15 min
Mean 498.3443 482.0804
Variance 28316.65 24757.53
Observations 51 51
Hypothesized Mean Dierence 0
df 100
t Stat 0.50416
p(T<=t)one-tail 0.307629
t Critical one-tail 1.660234
p(T<=t) two-tail 0.615258
t Critical two-tail 1.983971
Table 4.5: Signicance test for the nuclear size dierence before and after low
serum assay, in NMI depleted nuclei. data set 1
Second set of data
The analysis of this second set of images revealed that the nuclear size at 15
minutes of the low serum assay is much bigger compared to the nuclear area at
0 minute gure 4.6. The calculated t-test has conrmed this to be statistically
signicant, p value = 1.3710 6, result displayed in table 4.6. It seems that
incubating NMI depleted cells in low serum for 15 minutes has resulted in an
increase in the mean nuclear area of these cells.
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Figure 4.6: Comparison of the means nuclear area before and after the
low serum incubation of NMI depleted cells, data set 2
Blue : nuclear area at 0 minute (before the low serum assay) , pink : nuclear area at
15 minutes (after the low serum assay), standard error bars have been plotted, all
measurements are shown in m2
t-Test: Two-Sample Assuming Unequal Variances
NMI( ) nu-
clear area at
0 min
NMI( ) nu-
clear area at
15 min
Mean 535.8689 762.3461
Variance 24534.23 57182.38
Observations 44 44
Hypothesized Mean Dierence 0
df 74
t Stat -5.25528
p(T<=t)one-tail 6.8710 07
t Critical one-tail 1.665707
p(T<=t) two-tail 1.3710 06
t Critical two-tail 1.992543
Table 4.6: Signicance test for the nuclear size dierence before and after low
serum assay, in NMI depleted nuclei. data set 2
In order to check whether the increase of the nuclear size in data set 2,
observed after incubating the NMI depleted cells in low serum for 15 minutes was
actually due to the absence of the NMI from the nucleus or was just reecting
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a natural variation of the cells population; we repeated the same analysis in
negative control (NMI c) cells (cells transfected using non targeting siRNA).
The result obtained were similar to the previously observed dierence in data
set 2 of the NMI knocked down cells with a nuclear area after the 15 minutes
low serum incubation much more bigger then the nuclear area at 0 minute (cells
that have not been incubated in low serum media). As shown in gure 4.7, the t
test in this case, showed that this dierence is signicant; p value =6.9810 11
as displayed in table 4.7.
Figure 4.7: Comparison of the means nuclear area before and after the
low serum incubation of non NMI targeting siRNA transfected nuclei
1.
Blue: nuclear area at 0 minute (before the low serum assay), Pink: nuclear at 15
minutes(after the low serum assay), standard error bars have been plotted, all
measurements are shown in m2
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t-Test: Two-Sample Assuming Unequal Variances
NMI( C) nu-
clear area at 0
min
NMI( C) nu-
clear area at
15 min
Mean 367.2568 550.99
Variance 8006.035 19832.3
Observations 47 47
Hypothesized Mean Dierence 0
df 78
t Stat -7.54944
p(T<=t)one-tail 3.4910 11
t Critical one-tail 1.664625
p(T<=t) two-tail 6.9810 11
t Critical two-tail 1.990847
Table 4.7: Signicance test for the nuclear size dierence before and after low
serum assay, in negative control(NMI( C))cells, 1.
Since the comparisons of nuclear size before and after the low serum assay in
this rst set of siRNA negative control (NMI( C)) cells showed a similar trend
compared to the data set 2 of the NMI depleted cells (bigger nuclei after the low
serum incubation) it became obvious that silencing the NMI could not justify
the dierence in measured nuclei sizes before and after the low serum assay.
In order to test the probability that the transfection procedure is responsible
for this dierence, the same analysis has been carried out using a second set
of siRNA negative control cells (cells transfected using non targeting siRNA
oligonucleotides ). This time, the mean nuclear area at 15 minutes seemed to
be just above the mean nuclear area at 0 minute, gure 4.8. the t test has
conrmed this dierence to be insignicant with a p value = 0.76, as displayed
in table 4.8.
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Figure 4.8: Comparison of the means nuclear area before and after the
low serum incubation in non NMI targeting siRNA transfected nuclei
2.
Blue: nuclear area at 0 minute (before the low serum assay) , Pink: nuclear area at
15 minutes (after the low serum assay), standard error bars have been plotted, all
measurements are shown in m2
t-Test: Two-Sample Assuming Unequal Variances
NMI( C) nu-
clear area at 0
min
NMI( C) nu-
clear area at
15 min
Mean 533.1143 545.14152
Variance 42010.3844 28953.94272
Observations 46 46
Hypothesized Mean Dierence 0
df 87
t Stat 0.306212181
p(T<=t)one-tail 0.380087344
t Critical one-tail 1.66255735
p(T<=t) two-tail 0.760174687
t Critical two-tail 1.987608241
Table 4.8: Signicance test for the nuclear size dierence before and after low
serum assay, in siRNA NMI negative control(NMI( C))nuclei, 2.
Conclusion
The comparison of the nuclear size at 0 and 15 minutes of the low serum assay
after the NMI depletion, has revealed a signicant increase in nuclear size after
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the low serum incubation in one set of data while no signicant change has
been registered in the other set. A comparable pattern has been identied
in negative control cells (cells that have been transfected using non targeting
siRNA) obtained from cells issued from the same culture as data set 2. In this
case also, a signicantly larger mean nuclear area at 15 minutes compared to 0
minute was registered. Thus, we can conclude that even so there was signicant
dierence between nuclear areas before and after the low serum incubation in
NMI depleted nuclei, the observed dierence could not have been caused by the
silencing of the NMI, since a comparable dierence was also observed in negative
control cells where the NMI has not been targeted by the siRNA (negative
control 1). The probability that this dierence could be have been due the
transfection procedure itself, has been eliminated because, a separately non
targeting siRNA transfected sample (negative control 2) showed no signicant
dierence in the nuclear size before and after the low serum assay. Thus, the
apparent increase in nuclear size after the low serum incubation observed in
only one cells sample could not have been induced by the siRNA transfection
nor by the NMI depletion, as other samples showed no signicant dierence in
nuclear size before and after the low serum incubation. Hence, this dierence
was probably secondary to sample variations; repeating similar experiments in
the future should provide us with more conclusive evidence.
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4.2 Analysis of the nuclear shape
The aim of this study is to investigate if there are any changes in nuclear shape
that may have occurred as a result of silencing the nuclear myosin 1 gene by
siRNA, or that may be caused by the low serum assay before and/or after the
siRNA knockdown of the nuclear myosin I. We looked at the overall shape of nu-
clei by calculating the nuclear roundness or contour ratio (4 area/perimeter2).
The contour ratio for a circle is 1 and this ratio approaches 0 as the nucleus
becomes more lobulated (Erikson et al 2004). The values of the area and nu-
clear perimeter were obtained using the Scion image program, the rest of the
calculations were performed on an excel worksheet, then the t-test was used to
determine the signicance of the ndings.
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4.2.1 Investigating the eect of the low serum assay on
nuclear shape
In order to identify whether the low serum assay has had any eects on the
nuclear shape, we compared the results of the calculated nuclear contour ratio
(4 area/perimeter2) in normal proliferating cells before the low serum assay
(at 0 minute) with the nuclear contour ratio after the low serum incubation (at
15 minutes). All the compared cells were from same cultures at same passage,
and xed using the same procedure described in section 2.2.3 of chapter 2. The
results of the calculated contour ratio at 0 minute and 15 minutes, were quite
similar at (0.38) and (0.37) respectively results. To evaluate how signicant
these results , a t-test for two samples assuming unequal variances has been
calculated which conrmed that the dierence between the contour ratio of
cells at 0 minute and 15 minutes is statistically insignicant with a value of
p = 0.68, details of the t-test are displayed in table 4.9. This suggested that
there is no signicant dierence between the nuclear shape before and after the
low serum assay, hence subjecting the cells to low serum for 15 minutes had no
signicant eect on the nuclear shape.
t-Test: Two-Sample Assuming Unequal Variances
Nuclei contour
ratio at 0 min
Nuclei contour
ratio at 15 min
Mean 0.380799 0.377022
Variance 0.002185 0.002169
Observations 50 50
Hypothesized Mean Dierence 0
df 98
t Stat 0.404686
P(T<=t) one-tail 0.343295
t Critical one-tail 1.660551
P(T<=t) two-tail 0.68659
t Critical two-tail 1.984467
Table 4.9: Signicance test for the dierence in nuclear contour ratio before and
after the low serum assay
4.2. Analysis of the nuclear shape 76
4.2.2 Investigating the eect of NMI silencing on nuclear
shape
To investigate whether the siRNA knock down of the nuclear myosin I has
resulted in any changes in the nuclear shape, a comparison of the calculated
nuclear contour ratio was performed. First, this ratio was compared between
cells transfected with non targeting control siRNA and cells transfected with
NMI-targeting siRNA. The calculated nuclear contour ratio was then compared
in cells after they were subjected to the low serum assay for 15 minutes. Next
the comparison of the nuclear roundness before and after the low serum assay
has been performed on cells where the NMI gene has been silenced. In addi-
tion, the nuclear shape comparison before and after the low serum assay has
been repeated in siRNA negative control cells (cells that have been transfected
with the same reagent used for the knockdown of the NMI but with no siRNA
sequences/oligonucleotides).
Comparison of the nuclear shape of NMI(+) and NMI( ) at 0 minute
Using the blue channel (DAPI channel) images obtained from colour split of
FISH images of NMI expressing nuclei (gure 4.9), and NMI depleted nuclei
(gure 4.10) on the Scion image analysis software, the area and the perimeter
of each nuclei have been measured.
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Figure 4.9: HDFs, NMI(+) nuclei at 0 minute.
displays the blue channel of the FISH images of nuclei expressing the NMI before
the low serum assay, were obtained by colour channels spliting using the Corel
software. the blue channel corresponds to the DAPI staining (nuclei).
Figure 4.10: HDFs, NMI( ) nuclei at 0 minute.
displays the blue channel of the FISH images NMI depleted nuclei before the low
serum assay, were obtained by colour channels spliting using the Corel software. the
blue channel corresponds to the DAPI staining (nuclei).
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First data set
Using area and perimeter measurements of cells at 0 minute (before the low
serum assay) of the control cells, and similar measurements of cells at 0 minute
of nuclear myosin I supressed cells, the contour ratio for each set of cells was
calculated and compared, the results were respectively (=0.38) and (=0.32) .
The t-test has conrmed that this dierence between the nuclear contour at 0
minute before and after siRNA knockdown of the NMI, is statistically signicant
(P= 1.4910 7) as shown in table 4.10. In other words, nuclear shape of cells
at 0 minute is signicantly dierent from the nuclei shape of similar cells after
that the NMI gene have been silenced with nuclei getting more lobulated after
the siRNA.
t-Test: Two-Sample Assuming Unequal Variances
Contour ratio of
NMI(+) nuclei
at 0 min
Contour ratio of
NMI( ) nuclei
at 0 min
Mean 0.380799 0.325588
Variance 0.002185 0.002562
Observations 50 50
Hypothesized Mean Dierence 0
df 97
t Stat 5.666532
P(T<=t) one-tail 7.47E-08
t Critical one-tail 1.660715
P(T<=t) two-tail 1.49E-07
t Critical two-tail 1.984723
Table 4.10: Signicance test for the dierence in nuclear contour ratio before
and after the silencing of the NMI
Second data set
To verify whether these changes in nuclear lobulation followed a general trend,
a second set of images have been used to repeat the same study. It was evident
this time that this second set of data showed a dierent trend then what was
previously described in table 4.11. The nuclear contour ratio at 0 minutes before
the siRNA knock down of the NMI was found this time to be bigger after the
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NMI suppression. Despite fact that these ndings are opposite to the results
obtained from the previous analysis , the calculated t-test has also conrmed
their signicance, p = 0.02, as detailed in table 4.9.
t-Test: Two-Sample Assuming Unequal Variances
Contour ratio of
NMI(+) nuclei
at 0 min
Contour ratio of
NMI( ) nuclei
at 0 min
Mean 0.326362 0.360738
Variance 0.006204 0.002565
Observations 42 42
Hypothesized Mean Dierence 0
df 70
t Stat -2.379
P(T<=t) one-tail 0.010045
t Critical one-tail 1.666914
P(T<=t) two-tail 0.020091
t Critical two-tail 1.994437
Table 4.11: Signicance test for the dierence in nuclear contour ratio before
and after the silencing of the NMI
While the the calculated contour ratio for the First data seemed to become
smaller for nuclei where the expression of the NMI has been blocked , the second
data set showed an opposite trend with a bigger nuclear contour ratio in NMI
depleted nuclei. Meanwhile, the t test has conrmed both dierences to be
signicant.
Comparison of the nuclear shape of NMI(+) and NMI( ) at 15 minute
To asses the possible eects of the low serum incubation on the nuclear shape
of NMI depleted cell (NMI( )) , a comparison of the nuclear contour ratio has
been was established between normal proliferating cells (NMI(+)) that have
been incubated in low serum for 15 minutes (gure 4.11) and cells where the
NMI expression has been suppressed by the siRNA then incubated in low serum
(gure 4.12).
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Figure 4.11: HDFs, NMI(+) nuclei at 15 minutes
displays the blue channel of the FISH images of nuclei expressing the NMI after the
low serum assay, were obtained by colour channels spliting using the Corel software.
the blue channel corresponds to the DAPI staining (nuclei).
Figure 4.12: HDFs, NMI( ) nuclei at 15 minutes
displays the blue channel of the FISH images NMI depleted nuclei after the low
serum assay, were obtained by colour channels spliting using the Corel software. the
blue channel corresponds to the DAPI staining (nuclei).
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The results showed a smaller roundness ratio at 15 minutes for nuclei non
expressing the NMI suggesting that they are more lobulated than the nuclei
of cells expressing the NMI after the low serum incubation. The calculated t
test has conrmed this dierence to be statistically signicant with a p value =
0.015, as shown in table 4.12
t-Test: Two-Sample Assuming Unequal Variances
Contour ratio of
NMI(+) nuclei
at 15 min
Contour ratio of
NMI( ) nuclei
at 15 min
Mean 0.377861 0.352056
Variance 0.002179 0.003219
Observations 49 49
Hypothesized Mean Dierence 0
df 93
t Stat 2.458648
P(T<=t) one-tail 0.007898
t Critical one-tail 1.661404
P(T<=t) two-tail 0.015797
t Critical two-tail 1.985802
Table 4.12: Signicance test for the dierence in nuclear contour ratio before
and after the silencing of the NMI at 15 minute of the low serum assay
In order to verify whether these changes in nuclear lobulation represent a
general trend, a second set of images have been used to repeat the same study.
This second set of data showed a similar trend, with a signicantly smaller
nuclear contour ratio of NMI( ) at 15 minutes compared to NMI(+) at 15
minutes. The p value = 0.05, as shown in table 4.13.
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t-Test: Two-Sample Assuming Unequal Variances
Contour ratio of
NMI(+) nuclei
at 15 min
Contour ratio of
NMI( ) nuclei
at15 min
Mean 0.353302 0.376605
Variance 0.002744 0.003369
Observations 44 44
Hypothesized Mean Dierence 0
df 85
t Stat -1.97708
P(T<=t) one-tail 0.025637
t Critical one-tail 1.662979
P(T<=t) two-tail 0.051274
t Critical two-tail 1.988268
Table 4.13: Signicance test for the dierence in nuclear contour ratio before
and after the silencing of the NMI at 15 minute of the low serum assay, 2
Conclusion
It has emerged from the previous analysis that there is no signicant change in
the nuclear roundness ratio of nuclei after the the cells are subjected to the low
serum assay, meaning that incubating the cells in low serum assay for 15 minutes
had not aected the overall shape of the nuclei. On the other hand, the silencing
of the nuclear myosin I has resulted in a statistically signicant dierence of the
calculated nuclear contour ratio, between the NMI expressing cells and the NMI
depleted cells. The roundness ratio was found to signicantly increase in one
of the analysed set of images, giving indication that the nuclei lacking the NMI
are signicantly more lobulated compared to the cells expressing the NMI, it
has been also found to signicantly decrease in the other set of images. In
addition, the comparison of the nuclear shape after the low serum assay in
cells expressing the NMI and in cells depleted of the NMI has revealed that,
subjecting the cells where the NMI expression has been suppressed to the serum
incubation, resulted in the nuclei to become more lobulated. Therefore more
comparison analysis needs to be carried out to determine whether other factors
beside the nuclear myosin I knock down determine the trend of these changes
and thus the nuclear shape.
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4.3 Image analysis of chromosome 10 and X
territories
Chromosome 10 and X territories have been chosen for the image analysis study
because of their distinct behavior towards the low serum incubation, while chro-
mosome 10 was found to relocate from an intermediate to a peripheral position
after the low serum incubation, chromosome X was found to remain at the
nuclear periphery, from this point it was important to know these two chromo-
somes territories exhibited any changes secondary to the low serum incubation.
Furthermore, the eect of the NMI suppression on these chromosome territories
have been investigated. the sizes chromosome 10 and X territories have been
measured using the Scion image analysis software. using the green channel of
the respective FISH images.
4.3.1 Image analysis of chromosome 10 territories
Using the green channel of the FISH images of chromosome 10 territories ob-
tained before (gure 4.13) and after (gure 4.19) the low serum assay; the size
of the chromosome territory has been measured by the Scion image analysis
program then the results we compared and unpaired two sample t test was cal-
culated to asses the signicance of any resulting dierence.The same analysis
has been repeated using images of cells where the NMI expression has been
blocked using siRNA.
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Figure 4.13: Green channel of FISH images of chromosome 10 at 0
minute.
displays the green channel of the FISH images of nuclei expressing the NMI before
the low serum assay, were obtained by colour channels spliting using the Corel
software. the green channel corresponds to the Cy3 staining (CT).
Figure 4.14: Green channel of FISH images of chromosome 10 at 15
minutes.
displays the green channel of the FISH images of nuclei expressing the NMI after
the low serum assay, were obtained by colour channels spliting using the Corel
software. the green channel corresponds to the cy3 staining (CT).
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4.3.2 Comparison of chromosome chromosome 10 terri-
tories before and after the low serum assay
The size of chromosome 10 territories measured in nuclei of HDFs before the
low serum assay ( at 0 minute) was compared to the size of chromosome 10
territories measured after the low serum assay ( at 15 minutes). It seemed
that the chromosome 10 territories were getting smaller after the low serum
incubation, as shown in gure 4.15, the t test has conrmed the statistical
signicance of this dierence; p = 3.19  10( 13).
Figure 4.15: Comparison of the size of chromosome 10 at 0 and 15
minutes.1
Purple: the mean size of chromosome 10 territories before the low serum
incubation, Orange: the mean size of chromosome 10 territories after the low
serum incubation
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In order to verify whether, smaller chromosome 10 territories after the low
serum incubation is a general trend , a second set of images have been analysed.
Similar trend have also been registered with chromosome 10 territories becoming
smaller after the low serum incubation (gure 4.16), p = 0.39.
Figure 4.16: Comparison of the size of chromosome 10 at 0 and 15
minutes.2
Purple: the mean size of chromosome 10 territories before the low serum
incubation, Orange: the mean size of chromosome 10 territories after the low
serum incubation
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4.3.3 Comparison of chromosome 10 territories before
and after the low serum assay of NMI depleted
cells
The assess the eect of the suppression of the NMI on chromosome territories
sizes, the low serum assay has been repeated on cells where the NMI expression
has been blocked using siRNA. Results have shown that the size of chromosome
10 territories was nearly the same before and after the low serum incubation
of NMI depleted cells (gure 4.15). the t test has conrmed that there is no
signicant dierence in chromosome 10 territories at 0 and 15 minutes in NMI
depleted nuclei; p = 0.47.
Figure 4.17: Comparison of the size of chromosome 10 of NMI depleted
nuclei before and after the low serum incubation.
Purple: the mean size of chromosome 10 territories before the low serum
incubation, Orange: the mean size of chromosome 10 territories after the low
serum incubation
Conclusion
The comparison of the size of chromosome 10 territories in normal proliferating
HDFs has revealed signicant changes in the territory size after the cells have
been incubated in low serum assay for 15 minutes. Chromosome 10 territories
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seem to become smaller when the cells have been subjected to the low serum
assay. The same comparison have been repeated using cells where the expression
of the nuclear myosin I has been blocked by siRNA, in these cells, no signicant
change in the chromosome 10 territories' sizes has been identied. Chromosome
10 territories ahve similar sizes before and after incubating NMI depleted cells
in low serum for 15 minutes.
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4.3.4 Image analysis of chromosome X territories
Using the green channel of the FISH images of chromosome X territories ob-
tained before (gure 4.18) and after (gure??) the low serum assay; the size
of the chromosome territory has been measured by the Scion image analysis
program then the results we compared and unpaired two sample t test was cal-
culated to asses the signicance of any resulting dierence. The same analysis
has been repeated using images of cells where the NMI expression has been
blocked using siRNA.
Figure 4.18: Green channel of FISH images of chromosome X at 0
minute
displays the green channel of the FISH images of nuclei expressing the NMI before
the low serum assay, were obtained by colour channels spliting using the Corel
software. the green channel corresponds to the cy3 staining (CT).
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Figure 4.19: Green channel of FISH images of chromosome X at 15
minutes
displays the green channel of the FISH images of nuclei expressing the NMI after
the low serum assay, were obtained by colour channels spliting using the Corel
software. the green channel corresponds to the cy3 staining (CT).
4.3.5 Comparison of chromosome chromosome X terri-
tories before and after the low serum assay
The size of chromosome X territories measured in nuclei of normal proliferating
HDFs before the low serum assay (at 0 minute) was compared to the size of
chromosome X territories measured after the low serum assay (at 15 minutes).
It seemed that the chromosome X territories were bigger after the low serum
incubation, as shown in gure 4.20, the t test has conrmed the statistical
signicance of this dierence; p = 0.001.
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Figure 4.20: Comparison of the size of chromosome X at 0 and 15
minutes.
Green: the mean size of chromosome X territories before the low serum
incubation, Violet: the mean size of chromosome X territories after the low
serum incubation
4.3.6 Comparison of chromosome X territories before
and after the low serum assay of NMI depleted
cells
The assess the eect of the suppression of the NMI on chromosome territories
sizes, the low serum assay has been repeated on cells where the NMI expression
has been blocked using siRNA. Results have shown that the size of chromosome
X territories seemed to be bigger before the low serum incubation of NMI de-
pleted cells (at 0 minute) compared to the size of X territory at 15 minutes, as
shown in gure 4.21. despite the apparent dierence in chromosome X territo-
ries at 0 and 15 minutes of NMI depleted cells, the t test has conrmed that
this dierence was statistically insignicant, p = 0.39.
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Figure 4.21: Comparison of the size of chromosome X at 0 and 15
minutes of NMI depleted nuclei
Green: the mean size of chromosome X territories before the low serum
incubation, Violet: the mean size of chromosome X territories after the low
serum incubation
Conclusion
The image analysis of the chromosome X territories before and after the low
serum incubation has revealed signicant changes in the size of these territories
before and after the low serum assay. It has emerged that chromosome X ter-
ritory becomes bigger after incubating normal proliferating cells in low serum
for 15 minutes. In NMI depleted cells, subjecting the cells to low serum incuba-
tion resulted in no signicant dierence in the size of chromosome X territories
before and after the low serum assay .
Chapter 5
Discussions
5.1 Role of the nuclear myosin I in chromo-
some positioning
In this study we have been able to conrm that the myosin responsible for the
rapid chromosome 10 repositioning as result to low serum incubation is the
nuclear myosin I. Low serum induced chromosome 10 repositioning from an in-
termediate position in the nucleus to the nuclear periphery has been previously
identied by our to be depending on the function of both actin myosin (Mehta
& Bridger unpublished), with several myosins identied in the nucleus (see sec-
tion 4.2 chapter 1), it was important to know which of these nuclear myosin is
actually responsible for the rapid chromosome 10 repositioning to the nuclear
periphery. In this study, using RNA interference techniques to block the expres-
sion of the NMI gene performed on similar cultures and using same procedures,
we provide evidence that this rapid chromosome 10 repositioning is dependent
on the presence of the nuclear myosin I in the nucleus. By comparing the chro-
mosome 10 positions at 0 and 15 minutes of the low serum assay in control cells
before the siRNA transfection, with the respective chromosome positions at 0
and 15 minute of the low serum incubation repeated on cells where the NMI
expression have been blocked, we have found that the relocation of chromosome
10 to the nuclear periphery after 15 minutes of the low serum incubation, pre-
93
5.2. Role of the nuclear myosin I in maintaining nuclear shape 94
viously identied in normal proliferating control cells did not manifest in NMI
depleted nuclei. In nuclei where the NMI gene has been silenced using siRNA,
chromosome 10 have been found to occupy an intermediate position both at 0
and 15 minutes of the low serum assay. The role of nuclear myosin I in chro-
matin movements have been previously reported (Chang, et al., 2006, Dundr et
al., 2007, Hu, et al., 2008) but this is the rst time where a whole chromosome
territory relocation have been shown to be dependant on the presence of the
NMI in the nucleus. While these nding conrm a model where the interphase
chromatin is highly dynamic with NMI dependant active chromosome domains
repositioning.
5.2 Role of the nuclear myosin I in maintaining
nuclear shape
The image analysis of the nuclear shape before and after the siRNA silencing of
the nuclear myosin gene, has revealed signicant changes in the shape of nuclei
after the low serum incubation NMI depleted nuclei compared to nuclei of cells
where the expression of the NMI has not been aected, the nuclei where the
NMI expression has been blocked were found to become more lobulated after
the cells were subjected to the low serum assay. The low serum incubation of
cells expressing the NMI did not seem to have signicant eect on the shape
or the size of the nuclei. A role of NMI in maintaining the nuclear shape has
recently been suggested by Holaska and Wilson, (2007); NMI bound to emerin
can act as a sencor and a regulator of the peripheral nuclear lamina network.
In this study further evidence of the involvement of the nuclear myosin I in
maintaining the nuclear shape is provided.
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5.3 Eect of the nuclear myosin I on chromo-
some territories size
The analysis of chromosome 10 and X territories has revealed signicant changes
of the size of chromosome territories after the cells have been incubated in low
serum for 15 minutes. while the size of chromosome 10 territories seemed to
have shrunk after the low serum assay, the chromosome X territories seemed
to have expanded. These changes in chromosome territories' sizes are found
to be dependent on the presence of the nuclear myosin I in the nucleus, since
no signicant changes in both chromosome 10 and X territory size have been
registered when the NMI depleted cells have been subjected to the low serum
assay.
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5.4 Conclusion
The newly uncovered role of the NMI in chromosome repositioning brings to
mind the case of senescent cells where a study by Mehta, et al, (2010) has shown,
absence of the low serum induced chromosome repositioning initially observed
in normal proliferating cells. It is tempting to speculate that the abolishment of
the chromosomal repositioning in this case is comparable to the one observed in
this study when the NMI depleted cells were subjected to the low serum assay.
Thus, the absence of the low serum induced chromosome repositioning in senes-
cent cell, could reect or result from impairment in the function of the NMI.
In favour of this idea, is the striking dierence in the distribution of the NMI
in senescent cells compared to normal proliferating cells, observed by indirect-
immunouorescence (Mehta, et al ., 2010). Further studies are required to verify
this hypothesis, which could result in a breakthrough in the eld of progeria re-
search where a comparable pattern has been also observed (Mehta, et al., 2010).
The study of chromosome territories has also revealed that chromosome ter-
ritories (CT) are aected dierently by the low serum assay (while chromosome
10 territories seem to have shrunk in size, chromosome X territories have ex-
panded). It would be interesting to know whether these changes in CT sizes are
correlating with the transcriptional status of these chromosomes and how the
serum deprivation aects the CT sizes. Interestingly, the siRNA knockdown of
the NMI resulted in the absence of the low serum induced changes in CT sizes.
More studies are needed to investigate how the NMI is aecting the CT in serum
deprived cultures.
The results of this study have provided new insights into the importance of
the nuclear myosin I in nuclear organisation and architecture, this multi func-
tional motor has been found necessary for chromosome movements, maintaining
the nuclear shape, and aecting the chromosome territories sizes. The mecha-
nism by which the NMI is maintaining these functions and whether the NMI
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has been acting directly or indirectly (in a complex or as regulator), needs to
be further investigated.
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Nuclear motors and nuclear structures containing
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link?
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Abstract
Rapid interphase chromosome territory repositioning appears to function through the action of nuclear
myosin and actin, in a nuclear motor complex. We have found that chromosome repositioning when cells
leave the cell cycle is not apparent in cells that have mutant lamin A or that are lacking emerin. We discuss
the possibility that there is a functional intranuclear complex comprising four proteins: nuclear actin, lamin
A, emerin and nuclear myosin. If any of the components are lacking or aberrant, then the nuclear motor
complex involved in moving chromosomes or genes will be dysfunctional, leading to an inability to move
chromosomes in response to signalling events.
Interphase chromosome positioning
and repositioning
Chromosomes are positioned non-randomly in interphase
nuclei. In primary proliferating fibroblasts, chromosomes
are positioned according to their gene density, with gene-
poor chromosomes at the nuclear periphery and gene-rich
chromosomes towards the nuclear interior [1,2]. The gene-
density-correlated positioning of chromosomes found in
different cell types gave credence to the idea that positioning
of genes and regulatory elements at specific regions of the
nucleus would have an impact on the regulation of gene
expression or silencing. Some interphase chromosome pos-
itions alter with differentiation, whereas others remain
in the same nuclear location (reviewed in [3,4]), adding
further weight to the argument that interphase positioning
is relevant in genome function. On the other hand, we
have found that, when cells leave the proliferative cell cycle,
to become either quiescent or senescent, chromosomes are
still positioned non-randomly, but now according to size,
with large chromosomes at the nuclear periphery and small
chromosomes in the nuclear interior (I.S. Mehta, M. Figgitt,
L.S. Elcock, K.J. Meaburn, G. Bonne, I.R. Kill and J.M.
Bridger, unpublished work). Whether this change in location
influences changes in transcription profiles has yet to be
determined.
We found that, as fibroblasts became quiescent or sene-
scent, a number of chromosomes would change position and
some would remain at the same nuclear location. Quite a
few chromosomes, such as chromosomes 13 and 18, change
nuclear position as fibroblasts become non-proliferating and
Key words: chromosome movement, emerin, nuclear actin, nuclear lamin, nuclear motor,
nuclear myosin.
Abbreviations used: EDMD, Emery–Dreifuss muscular dystrophy; HGPS, Hutchinson–Gilford
progeria syndrome; NMI, nuclear myosin I.
1To whom correspondence should be addressed (email Joanna.Bridger@brunel.ac.uk).
relocate to same nuclear compartment regardless of whether
cells are quiescent or senescent (Figure 1). Others relocate,
but are found in different nuclear compartments in both
quiescent and senescent fibroblasts (I.S. Mehta, M. Figgitt,
L.S. Elcock, K.J. Meaburn, G. Bonne, I.R. Kill and J.M.
Bridger, unpublished work). Chromosome 10 is the most
interesting chromosome, since it is found in an intermediate
nuclear position in proliferating fibroblast nuclei (Figure 1A),
at the nuclear periphery in quiescent fibroblasts (Figure 1B)
and within the nuclear interior in senescent fibroblasts
(Figure 1C). Indeed, it is one of two chromosomes that are
located at three different nuclear locations in these cell states.
From these analyses, we have to conclude that chromosome
territories move, changing their nuclear location as cells
become senescent or quiescent (Figure 1). But whether this
was immediate, over a number of hours, or whether cells
are required to traverse mitosis for chromosomes to become
repositioned was not clear, and not trivial to study in
senescent cells. However, using serum removal, we were
able to show that chromosome territories are relocated very
rapidly, after 15 min. This repositioning is an active process
requiring energy, since inhibitors of ATPase and GTPase
block the relocation of chromosomes (I.S.Mehta, L.S. Elcock,
G. Bonne, I.R. Kill and J.M. Bridger, unpublished work).
Rapid repositioning has been observed for individual genetic
loci [5,6]. In order to understand how this rapid movement
is elicited, we are looking at nuclear motors.
Nuclear motors
Molecular motors of the cell cytoplasm have been studied
for many years. Over the years, there have been on/off
discussions as to whether there are molecular motors within
the nuclei of cells. The discussions started in the 1970s [7,8],
with a role for nuclear actin and myosin being suggested in
heterochromatin formation [9]. In the 1980s, evidence was
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Figure 1 Chromosomes occupy differential locations in normal proliferating, quiescent and senescent primary ﬁbroblasts
(A) In a young proliferating ﬁbroblast nucleus, chromosome 10 occupies an intermediate location, whereas chromosomes
13, 18 and X localize at the nuclear periphery. (B) In a young quiescent ﬁbroblast nucleus, this position of chromosomes is
altered and chromosome 10 localizes at the nuclear periphery, whereas territories for chromosomes 13 and 18 are positioned
in the nuclear interior. Chromosome X remains at the nuclear periphery. (C) In senescent cells, whereas chromosomes 13
and 18 are still localized in the nuclear interior, chromosome 10 is also observed to be positioned in the nuclear interior.
Chromosome X remains at the nuclear periphery.
provided that nuclear actin and myosin were involved in
nucleocytoplasmic transport [10], and, in the 1990s, more
ultrastructural studies were performed, localizing actin and
myosin in the nucleus [11,12]. Within the last 10 years,
scientists have uncovered several isoforms of myosin that are
found in nuclei, including NMI (nuclear myosin I) (reviewed
in [13]), myosin VI [14], myosin 16b [15] and myosin Va
[16]. In the 1970s, actin was also shown to be a nuclear
protein [17,18]. However, it is still an unresolved question
as to whether this actin in the nucleus is a polymerized or an
unpolymerized form [19].
Using microinjection of antibodies, actin [20,21], and actin
and myosin together [22], were shown to be involved in
RNA polymerase II transcription, which has been confirmed
further using drugs and mutant cell lines not only for nuclear
actin and NMI [13,23], but also for myosin VI [14]. These
acto–myosin motors also appear to be involved in RNA
polymerase I transcription [23–25].
Both nuclear actin and NMI have also been found
to associate with chromatin-remodelling complexes. Actin
binds to SWI/SWF-like BAF (barrier to autointegration
factor) remodelling complexes, whereas NMI associates
with components of the WICH (WSTF–SNF2h complex)
chromatin-remodelling complex [13].
However, the involvement of nuclear motors in transcrip-
tion and chromatin remodelling appears not to be their only
nuclear function. There is an increasing body of evidence
that they are also involved in movement of chromatin around
nuclei [5,26].
We have found that the rapid relocation of chromosomes
in interphase is blocked by drugs preventing polymerization
of actin and myosin (I.S. Mehta, L.S. Elcock, G. Bonne, I.R.
Kill and J.M. Bridger, unpublished work).
It is interesting to note that Hozak and colleagues found
that both nuclear actin and NMI are distributed quite
differently in resting non-stimulated lymphocytes compared
with PHA (phytohaemagglutinin)-stimulated lymphocytes
[27] and Riddle et al. [28] demonstrated that nuclear actin
was decreased in quiescent fibroblasts. We have stained
proliferating and senescent fibroblasts with a commercial
anti-NMI antibody and have seen quite different distribu-
tions of NMI in senescent cells compared with proliferating
fibroblasts; it could be described as disorganized (I.S. Mehta,
L.S.Elcock,M.Amira, I.R.Kill and J.M.Bridger, unpublished
work).
From our studies, we know that, when quiescent cells
are re-stimulated with serum, chromosomes do not relocate
to a proliferating gene-density distribution until after cells
have traversed mitosis with a breakdown and rebuilding
of the nucleus [29]. Thus we suggest that not only do
quiescent cells have a compromised nuclearmotor formoving
chromatin, but also the same is true for senescent cells,
since we have not visualized any chromosome repositioning
in senescent cells after removal of serum. This may
indicate that nuclear motors containing actin and myosin
do not function in the same manner in non-proliferating
cells with respect to dynamic chromatin/chromosome
movement.
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A-type lamins and emerin
The nuclear lamina is described as a meshwork [30] or a
uniparallel array [31] of interconnecting filaments underlying
the inner nuclear envelope. This structure, together with the
nuclear envelope and nuclear envelope proteins, is important
for organizing the structure of the entire nucleus and the
chromatin within it [32].
In most vertebrate cells, two major types of nuclear lamin
are found: A and B. A-type lamins are encoded by LMNA
which undergoes alternative splicing to form lamins A, delta
A, C and C2, whereas B-type lamins are encoded by two
separate genes LMNB1 and LMNB2 to form lamins B1, B2
and B3 (reviewed in [33]).
A-type lamin proteins not only are located at the nuclear
periphery, but also are probably part of the nuclear matrix
[34,35]. Further lamin proteins have been observed within
the nuclear interior [36,37] with sites of replication [38],
transcription factories [39] and splicing speckles [40].Nuclear
A-type lamins seem to be involved in many nuclear functions
such as nuclear structural integrity, DNA replication,
transcription, splicing, cell signalling, DNA repair, cellular
proliferation, transit of mitosis, organization and stability
of the genome, differentiation, normal aging, apoptosis and
epigenetic control of chromatin (reviewed in [41]).
A-type lamins have a number of binding partners, and this
might well explain their multifaceted roles and importance
within the nucleus, but this also adds another level of
complexity in assigning roles to particular complexes
of proteins containing A-type lamins. One of the binding
partners of nuclear A-type lamins is emerin (reviewed in
[32]). The lamin–emerin interaction has been implicated
to be important in maintaining the structural integrity of
the nucleus, in correct localization of the complex and in
efficient progression of the cell through the cell cycle [42].
The importance of this complex is emphasized by both
proteins causing similar diseases when the respective genes
are mutated, i.e. EDMD (Emery–Dreifuss muscular dys-
trophy). HGPS (Hutchinson–Gilford progeria syndrome) is
a premature aging syndrome caused by a base substitution in
the LMNA gene encoding a G608G mutation [43] resulting
in the formation of a truncated lamin A protein termed
progerin, which acts in a dominant-negative way [44]. Studies
on patients suffering from HGPS have revealed that lamins
are important in the maintenance of nuclear structure and
shape as well as in heterochromatin formation, chromatin
modification and gene expression [45]. Studies using emerin-
null cells derived from patients suffering from X-linked
EDMD have revealed that emerin may also influence gene
expression, heterochromatin organization and be involved in
maintaining the structural integrity of the nuclear envelope
(reviewed in [32]).
A-type lamins and emerin: are they
integral to the function of a nuclear motor?
If lamins A andC and emerin are involved in the function of a
nuclear motor comprising nuclear actin and nuclear myosins,
then there should be evidence that they bind one another in
Figure 2 Model showing the interactions between the nuclear
actin–myosin and the nuclear lamin–emerin complexes for
efﬁcient functioning of the nuclear motor
Nuclear lamins are known to bind to nuclear actin and nuclear eme-
rin. Nuclear emerin binds nuclear actin, nuclear myosin and nuclear
actin. Nuclear myosins are known to bind to DNA, whereas nu-
clear actin, emerin and lamins are known to interact with the nuclear
matrix. Thus chromosome territories are bound by nuclear myosins
which binds emerin which bind both nuclear actin and lamins. Thus
this four-protein complex, with the support of the nuclear matrix, may
function to move the chromosome territories within the nuclear space.
such a way as to form a complex. Indeed, in vitro studies
have demonstrated the binding of actin to the C-terminus
of lamin A [46]. In addition, the tail region of lamin A has
an additional site with affinity for actin [47]. Emerin binds
to both actin [F- (filamentous) and G- (globular) actin] and
NMI, revealed by proteomic studies [32]. Thus we know that
emerin binds lamin A that can bind to actin, which can bind
to both emerin and NMI which can bind emerin. This makes
an interesting hypothetical complex (Figure 2) and, although
it has been discussed as being present at the nuclear envelope
[48], could it also be present and functional throughout the
nucleus?
If this complex exists, does it function to move chro-
matin/chromosomes around the nucleus? We have started to
address this questionbyperforming chromosomepositioning
assays [two- and three-dimensional FISH(fluorescence in situ
hybridization)] in proliferating fibroblasts of patients that
have mutations in either LMNA or EMD genes (Figure 3B
and 3D) [49] and comparing chromosome positioning when
these cells have become senescent. Intriguingly, inHGPS cells
that have become senescent, the chromosomes do not alter
their nuclear location as theywould do in normal control cells
(Figure 3C). This implies that the nuclear motor function,
which would have been involved in chromosome movement
during transition from a proliferating to a senescent state, is
not functional. Indeed, anti-NMI antibody staining reveals
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Figure 3 Chromosome 10 localizes at the nuclear periphery in proliferating HGPS and EDMD ﬁbroblasts, and the position of chromosome
10 does not change once the cell is senescent
In senescent cells that are quiescent, the territories of chromosome 10 are in the nuclear interior (A). In primary proliferating
ﬁbroblasts derived from patients suffering from HGPS or EDMD, chromosome 10 territories are at the nuclear periphery
(B and D respectively), and this localization of chromosome 10 does not change when these HGPS cells become
senescent (C).
the same disorganized distribution of NMI as in senescent
cells (I.S. Mehta, L.S. Elcock, M. Amira, I.R. Kill and J.M.
Bridger, unpublished work).
If emerin is functionally involved in this complex, then
chromosomes would also not be relocated in EDMD cells
that became senescent. Unfortunately, we have only looked at
chromosomes 13 and 18 (Figure 3D) so far, and they are found
in the nuclear interior in both proliferating and senescent
EDMD cells [49].
Thus, for efficient movement of whole chromosome
territories, the formation and functionality of this protein
complex including nuclear actin, myosin, lamin and emerin
(Figure 2) may be vital. It has also been shown that, in normal
senescent cells, there is an accumulation of themutant formof
laminA [50,51]. Thismaywell explainwhy, in senescent cells,
chromosome 10 is not repositioned when senescent cells are
placed in low serum (Figure 3A), indicating that the nuclear
motor controlling chromosome movement in senescent cells
is dysfunctional.
In order to test these hypotheses and the functionality
of nuclear motors in non-proliferating and diseased cells,
we need to perform a number of experiments. These would
include interfering with the complex in normal cells as well
as rebuilding it in cells where this complex is dysfunctional
or missing; these studies are on-going in our laboratory.
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Open AccessR E S E A R C HResearchRapid chromosome territory relocation by nuclear 
motor activity in response to serum removal in 
primary human fibroblasts
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Chromosome positioning dynamicsNuclear myosin 1β-dependent repositioning of c r  territories occurs within 15 min-utes of serum starvat o  in human cells.
Abstract
Background: Radial chromosome positioning in interphase nuclei is nonrandom and can alter according to 
developmental, differentiation, proliferation, or disease status. However, it is not yet clear when and how chromosome 
repositioning is elicited.
Results: By investigating the positioning of all human chromosomes in primary fibroblasts that have left the 
proliferative cell cycle, we have demonstrated that in cells made quiescent by reversible growth arrest, chromosome 
positioning is altered considerably. We found that with the removal of serum from the culture medium, chromosome 
repositioning took less than 15 minutes, required energy and was inhibited by drugs affecting the polymerization of 
myosin and actin. We also observed that when cells became quiescent, the nuclear distribution of nuclear myosin 1β 
was dramatically different from that in proliferating cells. If we suppressed the expression of nuclear myosin 1β by using 
RNA-interference procedures, the movement of chromosomes after 15 minutes in low serum was inhibited. When high 
serum was restored to the serum-starved cultures, chromosome repositioning was evident only after 24 to 36 hours, 
and this coincided with a return to a proliferating distribution of nuclear myosin 1β.
Conclusions: These findings demonstrate that genome organization in interphase nuclei is altered considerably when 
cells leave the proliferative cell cycle and that repositioning of chromosomes relies on efficient functioning of an active 
nuclear motor complex that contains nuclear myosin 1β.
Background
Within interphase nuclei, individual chromosomes are
organized within their own nuclear space, known as
chromosome territories [1,2]. These interphase chromo-
some territories are organized in a nonrandom manner in
the nuclei of human cells and cells from other species [3].
Chromosomes in different species are positioned radially,
according to either their gene density [4-9] or their size
[10-12] or both [11,13-16]. The nuclear microenviron-
ment within which a chromosome is located could affect
its gene regulation, and it has been proposed that whole
chromosomes or regions of chromosomes are shifted
around the nucleus to control gene expression [17,18].
Active genes appear to come together in a common
nuclear space, possibly to be co-transcribed [19-21]. This
fits with the increasing number of observations made of
chromosome loops, containing active areas of the
genome, coming away from the main body of the chro-
mosome territory, such as regions containing FLNA on
the X chromosome [22]; major histocompatibility com-
plex (MHC) genes [23], specific genes on chromosome 11
[24]; β- globin-like genes [25], epidermal differentiation
complex genes [26], specific genes within the Hox B clus-
ter [27,28], and genes inducing porcine stem cell differen-
tiation into adipocytes [29]. Chromatin looping is
apparently associated with gene expression, because inhi-
bition of RNA polymerase II transcription affects the out-
ward movement of these chromosome loops [30].
Repositioning of whole chromosome territories has
been observed in erythroid differentiation [25], adipo-
genesis [31], T-cell differentiation [32], porcine sper-
matogenesis [33], and after hormonal stimulus [34]. Even
more studies revealed genomic loci being repositioned
during differentiation (see [35], for comprehensive
* Correspondence: joanna.bridger@brunel.ac.uk
1 Centre for Cell and Chromosome Biology, Division of Biosciences, School of 
Health Sciences and Social Care, Brunel University, Kingston Lane, Uxbridge, 
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in any medium, provided the original work is properly cited.
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Page 2 of 17review). We demonstrated previously that interphase
chromosomes occupy alternative nuclear positions when
proliferating cells become quiescent or senescent [5,7,9].
For example, chromosomes 13 and 18 move from a
peripheral nuclear location to an internal nuclear loca-
tion in serum-starved or senescent fibroblast cells [5,9].
From these early studies, it was not clear how other chro-
mosomes behaved after induction of growth arrest, and
so we have now positioned all human chromosomes in
cells made quiescent by serum starvation. We found that
just less than half of the chromosomes alter their nuclear
location. The ability to control, temporally, the entry of
cells to quiescence through serum starvation allows the
determination of a response time of nuclear architecture
to the change in environment. In this study, we demon-
strate that chromosome repositioning in interphase
nuclei occurs within 15 minutes.
The presence of actin [36] and myosin [37-41] have
been reported in nuclei, and an increasing body of evi-
dence suggests that they cooperate to form a nuclear
myosin-actin motor [42]. Actin and myosin have been
shown to be involved in the intranuclear movement of
chromosomal regions [43,44] and whole chromosomes
[34]. Further, nuclear actin and myosin are involved in
RNA polymerase I transcription [37,40], RNA poly-
merase II transcription [37-41], and RNA polymerase III
transcription [45]. In a model put forward by Hoffman
and colleagues [42], myosin I could bind through its tail
to the nuclear entity that requires movement, with actin
binding to the globular head of the nuclear myosin I mol-
ecule. This nuclear motor would then translocate the
nuclear entity along highly dynamic tracks of nuclear
actin [42]. In this study, we demonstrated that the rapid
movement of chromosome territories in response to
serum deprivation is dependent on the function of both
actin and myosin, probably nuclear myosin 1β.
Results
Interphase chromosome positioning in proliferating and 
nonproliferating cells
To determine the nuclear location of specific chromo-
somes, human dermal fibroblasts (HDFs) were harvested
and fixed for standard 2D-fluorescence in situ hybridiza-
tion (FISH). Representative images of chromosome terri-
tories in proliferating cells are displayed in Figure 1a-d.
Digital images were subjected to erosion analysis [4-
6,8,9], whereby the images of 4',6-diamidino-2-phenylin-
dole (DAPI)-stained flattened nuclei are divided into five
concentric shells of equal area, and the intensity of the
DAPI signal and probe signal is measured in each shell.
The chromosome signal is then normalized by dividing it
by the percentage of DAPI signal. The data for each chro-
mosome are then plotted as a histogram with error bars,
with the x-axis displaying the nuclear shells from 1 to 5,
representing the nuclear periphery to the nuclear interior,
respectively (Figure 1e-h).
In young proliferating fibroblasts, interphase chromo-
somes are positioned nonrandomly in a radial pattern
within nuclei [3]. In our 2D studies, we consistently found
gene-poor chromosomes, such as chromosomes X, 13,
and 18, located at the nuclear periphery [5,9], which fits
with their having more lamina-associated domains than
gene-poor chromosomes (see [46]). In this study, we
recapitulated the interphase chromosome positioning
with our present cultures and demonstrated that these
chromosomes are located at the nuclear periphery in
young proliferating cells (Figure 1b-d, f-h). Proliferating
cells within the primary cultures were identified by using
the proliferative marker, anti-pKi-67, which is distributed
in a number of different patterns within proliferating
human fibroblasts [47]. Its distribution is mainly nucleo-
lar and is shown in red (Figure 1a-d). Figure 1a and e
demonstrate the nuclear location of chromosome 10,
unlike chromosomes 13, 18, and X it is found in an inter-
mediate position in proliferating fibroblasts. The relative
interphase positions of chromosomes 10 and X have been
confirmed in 3D-FISH analyses (Figure 1i-k), whereby
HDFs were fixed to preserve their three-dimensionality
with 4% paraformaldehyde and subjected to 3D-FISH
[48]. Measurements in micrometers from the geometric
center the chromosome territories to the nearest nuclear
periphery, as determined by the DAPI staining, were
taken in at least 20 nuclei. The data were not normalized
for size measurements, so that actual measurements in
micrometers can be seen. However, all data were normal-
ized by a size measurement, and this not does alter the
relative positioning of the chromosomes.
We have evidence from prior studies that chromo-
somes such as chromosomes 13 [9] and 18 [5,9] alter their
nuclear position when primary fibroblasts exit the prolif-
erative cell cycle and that chromosome X remains at the
nuclear periphery [9]. However, this is only two chromo-
somes of 24, and so to determine which other chromo-
somes reposition after cell-cycle exit into quiescence
(G0), elicited through serum removal, we positioned all
human chromosomes in G0 cells (Figures 2 and 3).
To make cells quiescent, young, HDFs were grown in
10% NCS for 48 hours, and then the cells were washed
twice with serum-free medium and placed in 0.5% NCS
medium for 168 hours (7 days). However, when the posi-
tioning analysis was performed on the quiescent nuclei,
we found that certain chromosomes were in very differ-
ent positions from those in which they were found in pro-
liferating nuclei, that is, chromosomes 1, 6, 8, 10, 11, 12,
13, 15, 18, and 20 (Table 1).
The data demonstrated in Figure 3 and Table 1 reveal
that a number of chromosomes alter their nuclear posi-
tions when cells become quiescent; as shown before, both
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Chromosome positioning in proliferating interphase nuclei
Figure 1 Chromosome positioning in proliferating interphase nuclei. Proliferating human dermal fibroblasts (HDFs) cultures were subjected to 
2D- or 3D-fluorescence in situ hybridization (FISH) to delineate and analyze the nuclear location of chromosomes 10, 13, 18, and X. In panels (a-d), the 
chromosome territories are revealed in green with a single chromosome territory for chromosome X, because the HDFs are male in origin. The red 
antibody staining is the nuclear distribution of the proliferative marker anti-pKi-67, the presence of which denotes a cell in the proliferative cell cycle. 
DAPI (4',6-diamidino-2-phenylindole) in blue is a DNA intercalator dye and reveals the nuclear DNA. Scale bar = 10 μm. The histograms in panels (e-
h) display the distribution of the chromosome signal in 50 to 70 nuclei for each chromosome for 2D FISH, as analyzed with erosion analysis. This anal-
ysis divides each nucleus into five concentric shells of equal area, with shell 1 being the most peripheral shell, and shell 5 being the most interior shell 
[4-6,9]. The percentage of chromosome signal measured in each shell was divided by the percentage of DAPI signal in that shell. Bars represent the 
mean normalized proportion (percentage) of chromosome signal for each human chromosome. Error bars represent the standard error of the mean 
(SEM). Panels i and j display 3D projections of 0.2-μm optical sections through 3D preserved nuclei subjected to 3D-FISH and imaged with confocal 
laser scanning microscopy. The chromosome territories are displayed in red, and proliferating cells also were selected with positive anti-pKi-67 stain-
ing (not shown in reconstruction). Scale bar = 10 μm. The line graph in panel (k) displays a frequency distribution of micrometers from the geometric 
center of the chromosome territories to the nearest nuclear periphery, as defined by DAPI staining. Images for 20 nuclei were analyzed.
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(a) (b) (c) (d)
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Page 4 of 17chromosomes 13 and 18 move from a peripheral nuclear
location to an interior location (Figure 3m and r). Chro-
mosome 10 is one of a number of chromosomes that
move from an intermediate nuclear location to the
nuclear periphery (Figure 3j, Table 1), whereas chromo-
some X does not change its location at the nuclear
periphery (Figure 3w), and chromosomes such as 17 and
19 do not change their interior location (Figure 3q and s,
respectively).
It certainly appears that the chromosome positioning in
quiescent G0 cells is correlated with size. However, it is
not clear why a repositioning of chromosomes occurs
after serum removal and when and how it is elicited.
The movement of chromosomes when normal fibroblasts 
exit the cell cycle is rapid, active, and requires myosin and 
actin
To determine when the genome is reorganized on exit
from the cell cycle and the speed of the response to the
removal of growth factors, we took actively proliferating
young cultures of primary HDFs and replaced 10% NCS
medium with 0.5% NCS medium. Samples were taken at
0, 5, 10, 15, and 30 minutes after serum starvation for fix-
ation, and chromosome position in interphase was deter-
mined with 2D-FISH and erosion analysis (Figure 4 and
Additional file 1). Chromosomes 13 and 18 relocated
from the nuclear periphery to the nuclear interior within
15 minutes (Figure 4h and l), with an intermediate-type
nuclear positioning visible in the intervening time points
(5 and 10 minutes; Figure 4f, g, j, and k). In addition,
chromosome 10 moved from an intermediate location to
a peripheral location in the same time window (15 min-
utes; Figure 4d). Chromosome X did not relocalize at all,
as was reported previously [9] (Figure 4m-o), apart from
some slight difference at 15 minutes (Figure 4p).
In a previous study, we demonstrated that relocation of
chromosome 18 from the nuclear interior in G0 cells to
the nuclear periphery in serum-restimulated cells took
30+ hours and appeared to require cells to rebuild their
nuclear architecture after a mitotic division [5]. We
Chromosome positioning in quiescent interphase nuclei
Figure 2 Chromosome positioning in quiescent interphase nuclei. Representative images displaying nuclei prepared for fluorescence in situ hy-
bridization (2D-FISH), with whole-chromosome painting probes (green), and nuclear DNA is counterstained with 4',6-diamidino-2-phenylindole (DA-
PI) (blue). The cells were subjected to indirect immunofluorescence with anti-pKi-67 antibodies, and negative cells were selected. Cells were placed 
in low serum (0.5%) for 7 days, before fixation with methanol:acetic acid (3:1). The numbers (or letters) on the left side of each panel indicate the chro-
mosome that has been hybridized. Scale bar = 10 μm.
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Analysis of radial chromosome positioning in quiescent cell nuclei
Figure 3 Analysis of radial chromosome positioning in quiescent cell nuclei. Histograms displaying chromosome positions in primary human 
quiescent fibroblast nuclei. The 50 to 70 nuclei per chromosome were subjected to erosion analysis, which divides each nucleus into five concentric 
shells of equal area, with shell 1 being the most peripheral shell, and shell 5 being the most interior shell [4-6,9]. The percentage of chromosome signal 
measured in each shell was divided by the percentage of 4',6-diamidino-2-phenylindole (DAPI) signal in that shell. Bars represent the mean normalized 
proportion (percentage) of chromosome signal for each human chromosome. Error bars represent the standard error of mean (SEM).
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Page 6 of 17showed here that the same is true for chromosome 10,
with a return to an intermediate nuclear location 24 to 36
hours after restimulation of G0 cells with 10% NCS (Fig-
ure 5d-f). We again showed that chromosome 18 requires
similar times to return to the nuclear periphery (that is,
36 hours; Figure 5l). Although chromosome X remains at
the nuclear periphery, a slight change in the distribution
of chromosome X occurs at 32 to 36 hours (Figure 5q-r).
From these data, it seems that a rapid response to the
removal of growth factors reorganizes the whole genome
within the interphase nucleus, and this reorganization is
corrected in proliferating cells only after 24+ hours in
high serum, presumably after the cells have passed
through mitosis, as indicated by the peak of mitotic cells
at 24 to 36 hours after serum restimulation (0 hours,
none; 8 hours, none; 24 hours, 0.3%; 32 hours, 2.6%; and
36 hours, 1.2%).
Such rapid movement of large regions of the genome in
response to low serum implies an active process, perhaps
requiring ATP/GTP. When inhibitors of ATPase and/or
GTPase, ouabain, and AG10, were incubated with prolif-
erating cell cultures in combination with low serum,
chromosome 10 did not change nuclear location (Figure
6a-d, and see Additional file 3). The relocation to the
nuclear interior of chromosome 18 territories after incu-
bation of cells in low serum also was perturbed by these
Table 1: The position of all chromosome territories in primary human dermal fibroblasts as determined by 2D FISH, image 
acquisition, and erosion analysis
Chromosome by size Proliferating
HDFs
Quiescent
HDFs
1 IMb P
2 Pb P
3 Pd P
4 Pcd Pc
5 IMd IM
6 IMb P
7 P^ P
X Pab Pc
8 IMb P
9 Pd P
10 IMd P
11 IMd P
12 Pb I
13 Pa Ic
14 Ib I
15 Pb I
16 Ib I
17 Ib I
18 Pac Iac
19 Ia Ia
20 Id IM
22 Ib I
21 Ib I
Y I^ I
This table summarizes the locations of all the chromosomes in quiescent and proliferating nuclei of human dermal fibroblasts (HDFs). The 
positions of chromosomes shown without a symbol have been determined for this study. aData derived from [5]. bData derived from [4]. cData 
derived from [9]. dData derived from [7].
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Page 7 of 17inhibitors (Figure 6a-d). The control chromosome, chro-
mosome X, remained at the nuclear periphery (Figure 6
and Additional file 3). Because other studies suggest that
nuclear motors move genomic regions around the
nucleus by actin and/or myosin [42,44] we decided to use
inhibitors of actin and myosin polymerization to attempt
to block any chromosome movement elicited by these
nuclear motors when serum was removed. Latrunculin A,
an inhibitor of actin polymerization, inhibited the move-
ment of both chromosomes 10 and 18 when cells were
placed in low serum (Figure 7a and Additional file 3). In
contrast, phalloidin oleate, another inhibitor of actin
polymerization did not prevent relocalization of either
chromosome 10 or 18, when cells were placed in low
serum (Figure 7b and Additional file 3). However, two
inhibitors of myosin polymerization (BDM) and function
Rapid repositioning of chromosomes after removal of serum
Figure 4 Rapid repositioning of chromosomes after removal of serum. Chromosomes move rapidly in proliferating cells placed in low serum. 
The nuclear locations of human chromosomes 10 (a-d), 13 (e-h), 18 (i-l), and X (m-p) were analyzed in normal fibroblast cell nuclei fixed for 2D-FISH 
(fluorescence in situ hybridization) after incubation in medium containing low serum (0.5%) for 0, 5, 10, and 15 minutes. The filled-in squares indicate 
significance difference (P < 0.05) when compared with control proliferating fibroblast cell nuclei.
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Restoration of proliferative chromosome position after restimulation of G0 cells
Figure 5 Restoration of proliferative chromosome position after restimulation of G0 cells. The relocation of chromosomes to their proliferative 
nuclear location takes 24+ hours for chromosome 10 and 36 hours for chromosome 18. Proliferating cells (a, g, m) were placed in low serum (0.5%) 
for 7 days (b, h, n) and then restimulated to enter the proliferative cell cycle with the readdition of high serum. Samples were taken at 8 hours (c, i, o), 
24 hours (d, j, p), 32 hours (e, k, q), and 36 hours (f, l, r) after restimulation. The graphs display the normalized distribution of chromosome signal in 
each of the five shells. Shell 1 is the nuclear periphery, and shell 5 is the innermost region of the nucleus. The solid squares represent a significant 
difference (P < 0.05) for that shell when compared with the equivalent shell for the time 0 data (G0 data) for the erosion analysis.
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Page 9 of 17(Jasplakinolide; also affects actin polymerization) did
inhibit movements of both these chromosomes upon
serum removal (Figure 7c, d, and Additional file 3). Figure
7e provides a comparison for the rapid change in chro-
mosome position when no inhibitors are used. These data
imply that rapid chromosome movement observed in
cells as they respond to removal of growth factors is due
to an energy-driven process involving a nuclear
actin:myosin motor function.
Nuclear myosin 1β is required for chromosome territory 
repositioning in HDFs placed in low serum
In an effort to elucidate which myosin isoform was
involved in chromosome movement after serum removal
in culture, we used suppression by RNA interference with
small interfering RNAs (siRNAs). An siRNA pool for the
gene MYO1C was selected because it encodes for a cyto-
plasmic myosin 1C and the nuclear isoform nuclear myo-
sin 1β, a major candidate myosin for chromatin
relocation [39,49]. mRNA analysis had revealed insuffi-
cient differences in sequence for suppression of myosin
1β alone (data not shown). With a double transfection of
the siRNA, we observed 93% of cells displaying no
nuclear myosin staining at all (Figure 8k, q, and s) but still
with some cytoplasmic staining, whereas in the control
cells and the cells transfected with the control construct,
>95% of cells displayed a nuclear distribution of anti-
nuclear myosin 1β, which was distributed in proliferating
cells as accumulations at the inner nuclear envelope, the
nucleoli, and throughout the cytoplasm (Figure 8g-j, m-
p). These numbers did not change significantly after
serum removal for 15 minutes, as per the chromosome-
movement assay (data not shown).
After siRNA suppression of nuclear myosin, the chro-
mosome-movement assay was repeated by placing the
double-transfected cells into low serum for 15 minutes.
The graphs in Figure 9 show that chromosomes 10, 18,
and X behave as expected after removal of serum in the
control cells (Figure 9a-f) and in the cells transfected with
the control construct (Figure 9g-l), with chromosome 10
becoming more peripheral, chromosome 18 becoming
more interior, and chromosome X remaining at the
nuclear periphery. However, in the cells that had been
transfected with MYO1C-targeting siRNA, chromosome
movement was much less dramatic, with the chromo-
Chromosome repositioning requires energy
Figure 6 Chromosome repositioning requires energy. The relocation of human chromosomes 10 and 18 after incubation in low serum is energy 
dependent. The nuclear location of human chromosomes 10, 18, and X in were determined in normal human proliferating cell nuclei treated with 
ouabain (ATPase inhibitor) (a), AG10 (GTPase inhibitor) (b), or a combination of both (c) before and during incubation in low serum for 15 minutes. 
Normal control analysis data without any treatment is displayed in (d). The error bars show the standard error of the mean. The stars indicate a signif-
icant difference (P < 0.05) from cells treated only with the inhibitor.
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Page 10 of 17somes still residing in similar nuclear compartments
before and after the serum removal (Figure 9m-r).
The distribution of the nuclear myosin 1β is very inter-
esting in these cells, because it gives a nuclear envelope
distribution, a nucleolar distribution, and a nucleoplas-
mic distribution (Figure 10a-c). These distributions,
although revealing, are not so surprising, because nuclear
myosin has a binding affinity for the integral nuclear
membrane protein emerin [50] and is involved in RNA
polymerase I transcription [37,40,51]. The distribution in
quiescent cells is quite different, with large aggregates of
NM1β within the nucleoplasm and is missing from the
nuclear envelope and nucleoli. This distribution is similar
to that observed in senescent human dermal fibroblasts
(Mehta, Kill, and Bridger, unpublished data). With
respect to chromosome movement back to a proliferating
position after incubation in low serum, we showed that it
does not occur until 24 to 36 hours after repeated addi-
tion of serum to a quiescent culture (Figure 5) [5]. Corre-
lating with this is the rebuilding of daughter nuclei after
mitosis and the return of a proliferating distribution of
NM1β to the nuclear envelope, nucleoli, and nucleoplasm
(Figure 10g, j, p).
Discussion
This study completes the nuclear positioning of all 24
chromosomes in quiescent (serum-starved) normal pri-
mary HDFs, as assessed with 2D-FISH and erosion analy-
sis, with a number of chromosomal positions confirmed
in 3D-preserved nuclei. This study, which was performed
Chromosome repositioning requires nuclear myosin and actin
Figure 7 Chromosome repositioning requires nuclear myosin and actin. The relocation of human chromosomes 10 and 18 after incubation in 
low serum is myosin and actin dependent. The nuclear locations of chromosomes 10, 18, and X were determined in normal human proliferating cell 
nuclei treated with latrunculin A and phalloidin oleate (inhibitors of actin polymerisation) (a, b) and BDM and jasplakinolide (inhibitors of myosin po-
lymerization) (c, d) before and during incubation in low serum for 15 minutes. The error bars show the standard error of the mean. The stars indicate 
a significant difference (P < 0.05) from cells treated only with the inhibitor. Normal control analysis data without any treatment is displayed in (e).
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Page 11 of 17on similar cell cultures and in the same way as previous
studies, highlighted that some considerable difference
exists in chromosomal nuclear locations between prolif-
erating and quiescent cells. This difference cannot be due
to change in nuclear size or shape, because some chromo-
somes move toward the nuclear interior, some, to the
nuclear periphery, and some do not alter their location at
all; no significant difference is found between nuclear
shape and size before and after 15 minutes in low serum
(data not shown). Some suggestion exists of a size-corre-
lated distribution in quiescent cells (Table 1), with large
chromosomes toward the nuclear periphery, and small
chromosomes toward the nuclear interior. These results
also confirm the data previously presented, whereby
small chromosomes 13 and 18 had differential nuclear
locations with respect to proliferating and nonproliferat-
ing cells [5,9].
How and when the alterations to chromosome posi-
tioning occur are two fundamental questions in under-
standing the role of genome organization in cell cycle-
related events. The genome is probably anchored and
influenced through a number of interactions with nuclear
architecture [52,53], and so any signalled alterations/
modifications to these structures could enable a reorgani-
zation of the position of chromosome territories. We
know that when cells are made quiescent (for 7 days) and
are restimulated to enter the cell cycle by the repeated
addition of serum, chromosome 18 is not relocated back
to the nuclear periphery until the cells have been through
mitosis [5].
The question remained open as to when chromosomes
were repositioned after serum removal. We found that
repositioning of chromosomes was very rapid and com-
plete by 15 minutes. The types of repositioning (a) requir-
ing a rebuilding of the nucleus after mitosis, and (b) the
rapid response without a nuclear envelope breakdown,
imply that these processes follow different pathways and
mechanisms, and the latter is consistent with an energy-
dependent mechanism. This rapid movement of chromo-
somes after growth factor removal may be elicited
through a nuclear motor such as the actin/myosin motor-
complex, containing nuclear actin and nuclear myosin I,
previously shown to be involved in intranuclear move-
ments of chromatin [42-44]. This hypothesis was sup-
ported by experiments using inhibitors of ATPase and
GTPase, as well as inhibitors of actin and myosin polym-
erization. The actin polymerization inhibitor phalloidin
oleate did not inhibit chromosome movement on
removal of high serum. This is important because phal-
loidin has been shown not to bind to nuclear actin unless
the cells are treated with DMSO [54], which we had not
done.
These data support other literature describing nuclear
motors being involved in chromatin behavior [44]. These
drugs have an effect on a broad range of myosins, and so
we wanted to assess whether specific myosins were
involved; thus we used an siRNA sequence that success-
fully suppressed the levels of nuclear myosin 1β, as shown
by indirect immunofluorescence. This is the only nuclear
myosin that would have been affected, but we cannot rule
Suppression of nuclear myosin expression by short interference RNAs (siRNAs)
Figure 8 Suppression of nuclear myosin expression by short interference RNAs (siRNAs). Normal human dermal fibroblasts (HDFs) were trans-
fected with negative control or MYO1C targeting siRNA (double transfection) and samples for immunofluorescence staining and 2D-FISH (fluores-
cence in situ hybridization) were fixed 48 hours after the final transfection. Representative images of nuclei stained for anti-NMIβ (red) in control (g, h, 
m, n) cells transfected with negative control siRNA (i, j, o, p) and in cells transfected with MYO1C siRNA (k, l, q, r) after 0 and 15 minutes of serum 
starvation are displayed. The percentage of nuclei that are positive for NM1β in controls, in cells transfected with negative control siRNA, and in cells 
transfected with MYO1C siRNA are displayed in the adjacent table (s).
(b) (c) (d) (e) (f)
(g) (h) (i) (j) (k) (l)
(m) (n) (o) (p) (q) (r)
Immunofluoroscence staining for nuclear myosin1 beta
Column1 % of NMIβ posit ive nuc le i
Control 0 mins 99.3
Control 15 mins 99.6
NC 0 mins 99.1
NC 15 mins 99.6
Myo1C 0 mins 6.9
Myo1C 15 mins 5.4
S
(a)
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Page 12 of 17out that other myosins located within the cytoplasm
(such as myosin 1A and 1C), which may be suppressed as
well, could have a long-range interaction with chromatin,
through the nuclear envelope, possibly through nesprins
and SUN domain proteins [55,56].
However, the distribution of nuclear myosin 1β that we
observe in proliferating cells correlates with its properties
and functions, as described in the literature, and impli-
cates the nuclear envelope in chromosome/chromatin
movement. In previous studies, we analyzed chromo-
some position in cells that have defects of the nuclear
lamina, through mutations in nuclear lamin A or emerin,
both nuclear envelope proteins. These cells displayed a
nonproliferating distribution of chromosomes even
though they were proliferating [9,57]. The behavior of
nuclear motor proteins in these cells must be addressed.
Further, the distribution of NM1β from aggregates in qui-
escent cells to the nuclear envelope, nucleoli, and nucleo-
plasm is not observed until more than 24 hours after
serum readdition, which correlated with when specific
chromosomes become relocated from their quiescent
position to their proliferating location.
Conclusions
We demonstrated that some chromosomes occupy differ-
ent nuclear compartments in proliferating and serum-
starved quiescent cells. Most interestingly, this reposi-
tioning of chromosomes is very rapid, taking less than 15
minutes, and requires energy and active actin and myosin
function. The myosin involved could be nuclear myosin
1β, which has dramatically different distribution in quies-
cent nuclei as compared with proliferating cell nuclei.
Chromosome repositioning is inhibited by short interference RNA (siRNA) that suppresses nuclear myosin1β
Figure 9 Chromosome repositioning is inhibited by short interference RNA (siRNA) that suppresses nuclear myosin1β. Chromosome posi-
tioning was determined with 2D-FISH (fluorescence in situ hybridization) and erosion analysis, and the normalized position data plotted as histograms 
in control cells, in cells transfected with the negative control, and in cells transfected with the MYO1C siRNA construct. In control human dermal fibro-
blasts (HDFs) and in HDFs transfected with negative control, siRNA chromosome 10 is repositioned from an intermediate nuclear location (a and g, 
respectively) to the nuclear periphery (d, j) after 15 minutes of incubation in low serum. Chromosome 18 territories, conversely, are repositioned 
from the nuclear periphery (b, h) to the nuclear interior (e, k) after 15 minutes of incubation in low serum in control HDFs and in HDFs transfected 
with negative control siRNA. In HDFs transfected with the MYO1C siRNA construct, chromosomes 10 (m, p) and 18 (n, q) do not show repositioning 
after 15 minutes of incubation in low serum. Chromosome X remains at the nuclear periphery at all times (c, f, i, l, o, r). Unpaired, unequal variances 
two-tailed Students t tests were performed to assess statistical differences. The solid squares indicate a significant difference (P < 0.05) from cells not 
incubated in, and the solid circles indicate a significant difference (P < 0.05) from control HDFs.
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Cell culture
Human dermal fibroblasts (HDFs), 2DD [58] were grown
in Dulbecco's Modified Eagles Medium (DMEM) con-
taining 10% newborn calf serum (vol/vol NCS), glu-
tamine, and antibiotics, at 37°C. Cells were passaged
twice a week and seeded at a density of 3 × 103/cm2. Cells
were made quiescent by incubation in 10% NCS DMEM
for 2 days, washing in serum-free medium, followed by
incubation in DMEM containing 0.5% NCS (vol/vol) for 7
days.
Inhibitors of ATPase, GTPase, myosin, and actin 
polymerization
To inhibit the activity of ATPase or GTPase, cells were
treated with 100 μmol/L ouabain (Calbiochem-Novabio-
chem, Beeston, Nottingham, UK) for 30 minutes [59] or
with 100 μmol/L AG10 (Calbiochem) for 20 or 30 min-
utes before serum withdrawal [60,61], respectively. To
inhibit the polymerization of actin, cells were treated
with 1 μmol/L either Latrunculin A (Calbiochem) [62,63]
or phalloidin oleate (Calbiochem) [64] for 30 minutes.
Myosin polymerization was inhibited by treating cells
Anti-nuclear myosin 1b (NM1β) staining patterns in proliferating cells, quiescent cells, and after restimulation
Figure 10 Anti-nuclear myosin 1b (NM1β) staining patterns in proliferating cells, quiescent cells, and after restimulation. Normal 2DD hu-
man dermal fibroblasts (HDFs) were serum starved for 7 days to induce quiescence. The cells were then restimulated with fresh serum, and samples 
were collected at 0, 24, 36 and 48 hours after serum restoration. Samples were also collected before serum withdrawal (proliferating cells). The samples 
were then fixed with methanol/acetone (1:1), and the distribution of NMIβ was assessed by performing an indirect immunofluorescence assay for 
NMIβ. Images in (a, c) display the distribution of NMIβ in proliferating cells, whereas those in (d and f) show the distribution of NMIβ after 0, 24, 36 and 
48 hours after restimulation of quiescent fibroblasts. The table (p) displays the percentage of cells displaying various patterns of NMIβ staining after 
restimulation. Error is indicated by standard deviation. Scale bar = 10 μm.
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Page 14 of 17either with 10 mmol/L 2,3-butanedione 2-monoxime
(Calbiochem) for 15 minutes [65-67] or 1 μmol/L Jas-
plakinolide (Calbiochem) for 60 minutes [68]. See Addi-
tional file 5.
Fluorescence in situ hybridization
For the two-dimensional FISH assay, fibroblasts were har-
vested and placed in hypotonic buffer (0.075 mol/L KCl,
wt/vol) for 15 minutes at room temperature. After cen-
trifugation at 400 g, cells were fixed in 3:1 (vol/vol) meth-
anol/acetic acid (vol/vol) for 1 hour on ice. The fixation
step was repeated between 5 and 7 times before cells were
dropped onto humidified glass microscope slides. The
slides were aged at room temperature for 2 days or for an
hour at 70°C before being subjected to dehydration
through an ethanol series of 70%, 90%, and 100%, for 5
minutes each. The cells were denatured in 70% forma-
mide, 2 × sodium saline citrate buffer (SSC), pH 7, at 70°C
for 2 minutes. After denaturation, the slides were imme-
diately plunged into ice-cold 70% ethanol for 5 minutes
and then taken through the ethanol series and air-dried.
For three-dimensional FISH assay, fibroblasts were
washed in 1 × PBS and then fixed in 4% paraformalde-
hyde (wt/vol) in 1 × PBS for 10 minutes. The cells were
then permeabilized with 0.5% Triton-X100 (vol/vol) and
0.5% saponin (wt/vol) in 1 × PBS solution for 20 minutes.
The cells were then incubated in 20% glycerol, 1 × PBS
solution for at least 30 minutes before being snap-frozen
in liquid nitrogen. The cells were repeatedly frozen and
thawed for up to 5 times. After the freeze/thaw cycles, the
cells were then washed in 1 × PBS for at least 30 minutes
and then incubated in 0.1 N HCl for 10 minutes for
depurination. The cells were then washed in 2 × SSC for
15 minutes, with three changes of the buffer, and incu-
bated in 50% formamide, 2 × SSC, at pH 7.0, overnight.
For denaturation, cells were incubated at 73°C to 76°C in
70% formamide, 2 × SSC, pH 7 solution for 3 minutes and
then were immediately transferred to 50% formamide, 2 ×
SSC, pH 7 solution for 1 minute at the same temperature.
Chromosome paints for HSA 10, 13, 18, and X were
amplified from flow-sorted whole-chromosome tem-
plates and labelled with biotin-dUTP by DOP-PCR [69].
The 200- to 400-μg chromosome paints, 7 μg of C0t-1
DNA, and 3 μg of herring sperm were used per slide. All
other chromosome territories were delineated with
directly labelled whole human chromosome paints
(Qbiogene, Cambridge, UK). Probes were denatured at
70°C for 10 minutes with reannealing of repetitive
sequences at 37°C for 30 to 120 minutes. Hybridization
was performed in a humified chamber for 18 to 24 hours
at 37°C. The slides were washed in three changes of 50%
formamide, 2 × SSC, pH 7, at 45°C over a 15-minute
period, followed by three changes of 0.1 × SSC pre-
warmed to 60°C over a 15-minute period at 45°C.
The slides were then transferred to 4 × SSC at room
temperature. Slides hybridized with the in-house biotin-
labelled probes were then incubated with a blocking solu-
tion of 4% bovine serum albumin (BSA; Sigma Aldrich) of
4 × SSC followed by detection with streptavidin-cyanine
3 (Amersham Life Science Ltd; 1:200 dilution in 0.1%
BSA/4 × SSC). The slides were washed in three changes
of 4 × SSC/0.05% Tween 20 (vol/vol) for 5 minutes each.
Suppressing the expression of nuclear myosin 1β by 
interference RNA
To suppress nuclear myosin 1β expression, young prolif-
erating HDFs were seeded at 1 × 104 cells per well in a 12-
well plate. Transfection efficiency was previously deter-
mined with siGLO-labelled siRNA to be more than 95%.
The siRNA transfection was carried out with 2 μl Dhar-
mafect 1 and 50 μl of either negative control (2 μmol/L
ON-TARGETplus Non-targeting Pool; Thermo Scien-
tific) or myosin-targeting siRNA (2 μmol/L ON-TAR-
GETplus SMART pool, human MYO1C; Thermo
Scientific Cat number L-015121-00) in 200 μl serum-free
medium. Complete medium was added to the transfec-
tion mix to ensure that transfections were carried out in
serum-containing medium with a final siRNA concentra-
tion of 100 nmol/L per well/dish. Six hours after transfec-
tion, the medium in the well was replaced with normal
growth medium. At 24 hours after the first transfection, a
second identical transfection was performed to increase
the amount of suppression. Samples were collected at 48
hours after final transfection and fixed for 2D FISH and
indirect immunofluorescence.
Indirect immunofluorescence
Diluted rabbit anti-Ki-67 antibody (Dako; 1:1,500 dilu-
tion in PBS/1% NCS), 40 μl, was placed on the slides after
FISH for 1 hour at 37°C. Slides were washed in PBS for 15
minutes, with three changes. The slides were incubated
with 40 μl of swine anti-rabbit secondary antibody conju-
gated either to fluorescein isothiocynate (FITC, Dako) or
to tetrarhodamine isothiocynate (TRITC, Dako) (1:30
dilution in 1% NCS/PBS) for 1 hour at 37°C.
For anti-nuclear myosin 1β staining, cells were grown
on glass coverslips and fixed in 1:1 (vol/vol) methanol/
acetone for 10 minutes on ice. Rabbit anti-NM1β (Sigma-
Aldrich) was diluted in PBS/1% NCS (1:200) and incu-
bated with the fixed cells at room temperature for 1 hour
after washing thrice in PBS swine anti-rabbit conjugated
to tetrarhodamine isothiocyanate was incubated for 1
hour at room temperature.
Thereafter the slides were washed in PBS with three
changes over a 15-minute period and mounted in self-
sealing Vectashield mounting medium (Vector Laborato-
ries) containing the counterstain 4, 6-diamidino-2-phe-
Mehta et al. Genome Biology 2010, 11:R5
http://genomebiology.com/2010/11/1/R5
Page 15 of 17nylindole (DAPI).
Image capture and analysis
Two-dimensional FISH
Digital grey-scale images of random nuclei were captured
by using a Photometrics cooled charged-coupled device
(CCD) camera, pseudocolored, and merged by using Dig-
ital Scientific software, the Quips Pathvysion, Smart Cap-
ture VP V1.4, a Leica fluorescence microscope (Leitz
DMRB) with Plan Fluotar 100 × oil-immersion lens. The
images were run through a simple erosion script in IPLab
spectrum software, as described in [4]. The DAPI image
of the nucleus is outlined and divided into five concentric
shells of equal area, the first shell being most peripheral,
and the innermost denoting the interior of the nucleus.
The script measures the pixel intensity of DAPI and the
chromosome probe in these five shells. The probe signal
was normalized by dividing the percentage of the probe
by the percentage of DAPI signal in each shell. Histo-
grams were plotted with standard error bars representing
the standard error of the mean (± SEM). Simple statistical
analyses were performed by using the unpaired two-
tailed Student's t test with Microsoft Excel.
Three-dimensional FISH
The images of nuclei prepared by three-dimensional
FISH were captured by using a Nikon confocal laser scan-
ning microscope (TE2000-S) equipped with a 60 ×/1.49
Nikon Apo oil-immersion objective. The microscope was
controlled by Nikon confocal microscope C1 (EZ-C1)
software, version 3.00. Stacks of optical sections with an
axial distance of 0.2 μm were collected from 20 random
nuclei. Stacks of eight-bit grey-scale 2D images were
obtained with a pixel dwell of 4.56, and eight averages
were taken for each optical image. The positioning of
chromosomes in relation to the nuclear periphery was
assessed by performing measurements with Imaris Soft-
ware (Bitplane Scientific Solutions), whereby the distance
in micrometers between the geometric center of each
chromosome territory and the nearest nuclear periphery,
as determined with DAPI staining, in three dimensions.
These data were not normalized for size, but when the
data were normalized by dividing by the length of the
major axis + the length of the minor axis divided by 2, or
the length of the major axis alone, the relative positions of
the individual chromosomes in frequency distributions
did not change.
Frequency distribution curves were plotted with the
distance between the geometric center of chromosome
territory and the nearest nuclear periphery on the x-axis
in actual micrometers, and the frequency, on the y-axis.
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